Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà
MedNavigator.ru - Ïîèñê è ïîäáîð ëå÷åíèÿ â Ðîññèè è çà ðóáåæîì

Âåðíóòüñÿ   Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà > Èíôîðìàöèÿ è êîììåð÷åñêàÿ ðåêëàìà > Îçîíîòåðàïèÿ

Îçîíîòåðàïèÿ Ðàçäåë çàêðûò äëÿ ïóáëèêàöèè ñîîáùåíèé.

 
 
Îïöèè òåìû Ïîèñê â ýòîé òåìå Îïöèè ïðîñìîòðà
  #16  
Ñòàðûé 27.09.2003, 21:29
Zhivov Zhivov âíå ôîðóìà
Âåòåðàí ôîðóìà
      
 
Ðåãèñòðàöèÿ: 20.08.2001
Ñîîáùåíèé: 3,792
Zhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Æóëèêè è øàðëàòàíû ìíå, Âëàäèìèð ßêîâëåâè÷, íå êîíêóðåíòû.  ïåðå÷èñëåííûõ âàìè ËÓ è øàðëàòàíîâ è ïðîñòî ìàëîãðàìîòíûõ âðà÷åé áîëüøå ÷åì äîñòàòî÷íî, íåñìîòðÿ íà âíóøàþùèå âàì òðåïåò íàçâàíèÿ. Íó à Âû âñå æå ñ ïÿòèñîòîãî ïðåäëîæåíèÿ ìîæåò ïðî÷èòàåòå õîòÿ áû ïðåäèñëîâèå ê êíèæêå ïî êëèíýïèäåìèîëîãèè è ïîéìåòå ðàçíèöó ìåæäó ÷üèì òî âïå÷àòëåíèåì è íàó÷íûì ôàêòîì. Íåñìîòðÿ íà âàøå óïîðñòâî, ÿ íå òåðÿþ íàäåæäó íà âàøå ïðîçðåíèå.  ïðîòèâíîì ñëó÷àå ðàñïðîñòðàíåíèå øàðëàòàíñêèõ ìåòîäèê â ìåäèöèíå äîâåäåò âàñ ðàíî èëè ïîçäíî äî òîãî æå, äî ÷åãî óæå äîâåëî âàøèõ ôëîðèäñêèõ åäèíîìûøëåííèêîâ.

×òî äî ïðèâåäåííûõ ìíîþ ôàêòîâ èç ëè÷íîãî îáùåíèÿ, ÿ åñòåñòâåííî, íèêàêèõ èìåí íàçûâàòü íå áóäó ïî ýòè÷åñêèì ïðè÷èíàì. ïðîñòî âåäü ìåäèöèíñêîãî ñìûñëà äëÿ ïðèìåíåíèÿ ÎÒ íèêòî íå äîêàçàë, çíà÷èò îñòàåòñÿ òîëüêî äâà ñìûñëà: ïàðàíîÿëüíàÿ âåðà êàê ó Âàñ è æåëàíèå ïîäçàðàáîòàòü. Íè÷åãî äðóãîãî.

Êîììåíòàðèè ê ñîîáùåíèþ:
îäîáðèë(à): êàæäûé äóìàåò ïî ìåðå ñâåé èñïîð÷åííîñòè.Ìíå êàæåòñÿ ÷òî âû ïðîñòî ìîäåðàòîð...à íå âðà÷
  #17  
Ñòàðûé 28.09.2003, 02:43
V. ZAITSEV V. ZAITSEV âíå ôîðóìà Ïîë ìóæñêîé
çàáàíåí
      
 
Ðåãèñòðàöèÿ: 25.07.2001
Ñîîáùåíèé: 3,330
V. ZAITSEV
Àãà, à îçîíîòåðàïåâòîâ, êîòîðûå Âàì êàê íà äóõó ïðèçíàâàëèñü, íå íàçîâåòå, ïî ïðè÷èíå òàéíû èñïîâåäè, ïðàâäèâûé Âû íàø? Èíòåðåñíî, õîòü êòî-íèáóäü, ïóñòü èç Âàøèõ ñòîðîííèêîâ íà ôîðóìå Âàì âåðèò?
Ñðåäè «øàðëàòàíîâ è ïðîñòî ìàëîãðàìîòíûõ âðà÷åé» ÍÖ ÀÃèÏ ÐÀÌÍ, ïî-âèäèìîìó, è àêàä. ÐÀÌÍ Â.Í.Ñåðîâ. ß ïðèâîäèë çäåñü åãî âûñêàçûâàíèå î ïåðñïåêòèâàõ îçîíîòåðàïèè. Ïðàâäà, Âëàäèìèð Íèêîëàåâè÷, âûñêàçàë ñâîè ñîîáðàæåíèÿ íà îñíîâàíèè ñåìèëåòíåé ïðàêòèêè, èññëåäîâàíèé ÎÒ â åãî èíñòèòóòå, à âåëèêîìó À.Â. Æèâîâó, ÷òîáû äàòü îêîí÷àòåëüíóþ îöåíêó, âïîëíå äîñòàòî÷íî âûó÷èòü íàçâàíèå òåðàïèè.
P.S. Âûñî÷àéøåå ñàìîìíåíèå Àëåêñåé Âèêòîðîâè÷à óæå äàâíî íå ñåêðåò, îí áåçàïåëëÿöèîííî ñóäèò îáî âñåì, âíå çàâèñèìîñòè îò çíàíèÿ ïðåäìåòà. À â ñâÿçè ñ òåì, ÷òî, ïî îöåíêå Àëåêñåé Âèêòîðîâè÷à, 95% Ðîññèéñêèõ ìåäèêîâ áåçäàðíû è áåçãðàìîòíû, âðà÷àì (â òîì ÷èñëå, áóäóùèì) ôîðóìà, æåëàþùèì ïîïàñòü â îñòàâøèåñÿ 5%, íåîáõîäèìî êàê ìîæíî ÷àùå âòîðèòü åìó, îñîáåííî â êðèòèêå è ðàçîáëà÷åíèÿõ. (Ýòî íèêîåì îáðàçîì íå îòíîñèòñÿ ê ðÿäó äåéñòâèòåëüíî êëàññíûõ, çíàþùèõ ñåáå öåíó ñïåöèàëèñòîâ ôîðóìà, íå ñòðåìÿùèõñÿ, ïî÷åìó–òî, òàêèì îáðàçîì ïîïàñòü â ýëèòó).
  #18  
Ñòàðûé 28.09.2003, 16:42
Zhivov Zhivov âíå ôîðóìà
Âåòåðàí ôîðóìà
      
 
Ðåãèñòðàöèÿ: 20.08.2001
Ñîîáùåíèé: 3,792
Zhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Âäàäèìèð ßêîâëåâè÷.
Áîëüøèíñòâî âðà÷åé ôîðóìà ïðîñòî ïîðîé íå ãîâîðÿò âàì âñþ ïðàâäó â ãëàçà, ñêðîìíè÷àþò, íå ñ÷èòàþò íóæíûì è ò.ä. Õîòèòå çíàòü ïî÷åìó? Âîçìîæíî ïðîñòî èç âåæëèâîñòè. À âîçìîæíî è ïðîñòî ïîòîìó (ìîå ëè÷íîå ìíåíèå), ÷òî îíè â îñíîâíîì âñå ðàáîòíèêè ãîñó÷ðåæäåíèé è ïîðîé îïàñàþòñÿ, ÷òî êàêîé íèáóäü àêàäåìèê (õîòü ì øàðëàòàí), ïîëüçóÿñü ñâîèìè ñâÿçÿìè ìîæåò èì íàâðåäèòü. Ìíå àêàäåìèê ìîæåò íàâðåäèòü òîëüêî â ñóäå, ãäå åìó (åñëè îí øàðëàòàí) âðÿä ëè óäàñòñÿ äîêàçàòü, íàïðèìåð, ÷òî ÎÒ íå øàðëàòàíñòâî è ÿ êîãî òî òàì îêëåâåòàë. ß âåäü âíå âñåõ êàôåäð è îòäåëåíèé (õîòÿ ñîòðóäíè÷àþ î÷åíü ñî ìíîãèìè), êîòîðûå ñîçäàíû ãîñóäàðñòâîì è èì æå ñîäåðæàòñÿ. ß ñîäåðæó ñåáÿ è ñâîèõ ñîòðóäíèêîâ (òî÷íåå îíè ñåáÿ) ñàì. Ïîýòîìó ìîãó ñåáå ïîçâîëèòü ãîâîðèòü íåìíîãî áîëüøå è íå òîëüêî â èíòåðíåòå. Ê ñëîâó ñêàçàòü ñ äåéñòâèòåëüíî ãðàìîòíûìè è òîëêîâûìè ñïåöèàëèñòàìè â ìîåé ïðîôåññèè, îò ìåäñòóäåíòà è îðäèíàòîðà äî àêàäåìèêà ó ìåíÿ ïðåêðàñíûå îòíîøåíèÿ. ×òî êàñàåòñÿ ìîèõ êîëëåã ñêëîííûõ ê îçîíîòåðàïèè è ïðî÷åìó øàðëàòàíñòâó, ÿ èì ãîâîðþ â ãëàçà òî, ÷òî äóìàþ íå âçèðàÿ íà ëèöà. Îïÿòü æå çàáîòÿñü î ìîëîäîì ïîêîëåíèè ÷àùå âñåãî. Ýòî èìåííî î òåõ, êòî õî÷åò ïîïàñòü â 5%.

Êñòàòè ýòîò ïðîöåíò â ïîñëåäíèå ãîäû ðàñòåò. Áèáëèîòåêà íàøåé êëèíèêè, â ÷àñòíîñòè, âñå áîëåå âîñòðåáîâàíà. Ýòî è ñòóäåíòû, è àñïèðàíòû è ó æå âïîëíå çðåëûå ñïåöèàëèñòû. Çà ïîñëåäíèå 5-7 ëåò âñå áîëüøå ëþäåé èíòåðåñóþòñÿ äîêàçàòåëüíîé ìåäèöèíîé, ñòðåìÿòñÿ ïîó÷èòüñÿ íà Çàïàäå. Òàê ÷òî êðóã ñòîðîííèêîâ øàðëàòàíñêîé ïñåâäîìåäèöèíû áóäåò â Ðîññèè ñóæàòüñÿ, Âëàäèìèð ßêîâëåâè÷. Ïðîãðåññ âåäü ÿâíî íå â ñòîðîíó îçîíîâûõ óâëå÷åíèé èäåò.

Àãà, à îçîíîòåðàïåâòîâ, êîòîðûå Âàì êàê íà äóõó ïðèçíàâàëèñü, íå íàçîâåòå, ïî ïðè÷èíå òàéíû èñïîâåäè, ïðàâäèâûé Âû íàø?
Ñ òàêèìè îçîíòåðàïåâòàìè êàê Âû ÿ çíàêîìñòâ íå èùó è ñ íèìè íå îáùàþñü. Ïðî òî, çà÷åì õî÷åò âíåäðèòü ÎÒ â ñâîåì ËÓ ìíå ðàññêàçûâàë, â ÷àñòíîñòè, îäèí èç ñîòðóäíèêîâ ÷àñòíîé êëèíèêè ÑÏá. Êñòàòè â Ïèòåðå ýòîò âèä øàðëàòàíñòâà, ñëàâà Áîãó, ìåíåå ðàñïðîñòðàíåí ÷åì â Ìîñêâå.

Ñðåäè «øàðëàòàíîâ è ïðîñòî ìàëîãðàìîòíûõ âðà÷åé» ÍÖ ÀÃèÏ ÐÀÌÍ, ïî-âèäèìîìó, è àêàä. ÐÀÌÍ Â.Í.Ñåðîâ.
Âîçìîæíî è òàê. Îí ìîæåò âûñêàçûâàòüñÿ î ÷åì óãîäíî, â òîì ÷èñëå âûñêàçûâàòüñÿ îøèáî÷íî. Åãî ñòàòóñ àêàäåìèêà âåäü ýòî îäíî äåëî. À òî, ÷òî íè îí, íè åãî êîëëåãè íå óäîñóæèëèñü (ïðåæäå ÷åì âûñêàçûâàòüñÿ) ïðîâåñòè èññëåäîâàíèÿ ÎÒ â ñîîòâåòñòâèè ñî ñòàíäàðòàìè GCP (äóìàþ, ÷òî îíè âïîëíå ïðèíèìàþò ýòè ñòàíäàðòû, àáñîëþòíî ñîãëàñíû ñ íèìè, â ïðîòêîêîëàõ òî ó÷àñòâóþò, íå èíà÷å) èëè õîòÿ áû îçíàêîìèòüñÿ ñ òàêèìè èññëåäîâàíèÿìè (êîòîðûõ ïðîñòî íåò) - ýòî ñîâñåì äðóãîå. Àêàäåìèê, êîòîðûé âûñêàçûâàåòñÿ î ïåðñïåêòèâàõ êàêîãî-ëèáî ìåòîäà â ìåäèöèíå íå îñíîâûâàÿñü íà äàííûõ èññëåäîâàíèÿ åãî ýôôåêòèâíîñòè âûñîêîé äîêàçàòåëüíîñòè - ïðîñòî ïîçîðèò ñâîå çâàíèå è äîáðîå èìÿ. Âîò Ãàëèíà Àôàíàñüåâíà Ìåëüíè÷åíêî, êîòîðàÿ òîæå ñ Áîæåé ïîìîùüþ âîçìîæíî ñòàíåò Àêàäåìèêîì, íèêîãäà â òàêîì äóõå íå âûñêàçûâàëàñü áû, ÿ óâåðåí. Ïîýòîìó åñòü Àêàäåìèêè è "àêàäåìèêè", Ïðîôåññîðà è "ïðîôåññîðà", Âðà÷è è "âðà÷è". À òî, ÷òî âàì ýòè ïîðîé òóôòîâûå çâàíèÿ è ãðîìêèå íàçâàíèÿ ËÓ âíóøàþò òàêîé òðåïåò - ïðîñòî ñìåøíî.

à âåëèêîìó À.Â. Æèâîâó, ÷òîáû äàòü îêîí÷àòåëüíóþ îöåíêó, âïîëíå äîñòàòî÷íî âûó÷èòü íàçâàíèå òåðàïèè.
Ìíå ñêðîìíîìó äîêòîðó âïîëíå äîñòàòî÷íî çíàòü, ÷òî ÎÒ íå âõîäèò â ñòàíäàðòû ëå÷åíèÿ íè îäíîé áîëåçíè ÷åëîâåêà è ñ÷èòàåòñÿ îòïåòûì øàðëàòàíñòâîì êàê â ÑØÀ, òàê è â Åâðîïå. Åâãåíèé Ñòóäåíöîâ, êñòàòè, ïðèâåë ýòîìó íåêîòîðûå äîêàçàòåëüñòâà.

Âûñî÷àéøåå ñàìîìíåíèå Àëåêñåé Âèêòîðîâè÷à óæå äàâíî íå ñåêðåò, îí áåçàïåëëÿöèîííî ñóäèò îáî âñåì, âíå çàâèñèìîñòè îò çíàíèÿ ïðåäìåòà.
Ïîïðîøó íå îáîáùàòü. Ñóæó òîëüêî î òîì, ÷òî çíàþ õîðîøî. Âîò çíàþ õîðîøî, ÷òî ÎÒ íè îäèí ïîðÿäî÷íûé âðà÷ ìèðà, à òàêæå íè îäíà ïîðÿäî÷íàÿ ïðîôàññîöèàöèÿ âðà÷åé ìåòîäîì ëå÷åíèÿ íå ñ÷èòàåò. Òàê è ãîâîðþ.

À â ñâÿçè ñ òåì, ÷òî, ïî îöåíêå Àëåêñåé Âèêòîðîâè÷à, 95% Ðîññèéñêèõ ìåäèêîâ áåçäàðíû è áåçãðàìîòíû, âðà÷àì (â òîì ÷èñëå, áóäóùèì) ôîðóìà, æåëàþùèì ïîïàñòü â îñòàâøèåñÿ 5%, íåîáõîäèìî êàê ìîæíî ÷àùå âòîðèòü åìó, îñîáåííî â êðèòèêå è ðàçîáëà÷åíèÿõ
Íå íàäî ïûòàòüñÿ ìåíÿ ïîñîðèòü ñ ðîññèéñêèìè âðà÷àìè, Âëàäèìèð ßêîâëåâè÷. Òî, ÷òî ìîè ñîîòå÷åñòâåííèêè Ðîññèéñêèå ìåäèêè áåçäàðíû - íå ãîâîðèë íèêîãäà. Íàïðîòèâ, ñ÷èòàþ èõ îäíèìè èç ñàìû=õ òàëàíòëèâûõ â ìèðå. Ýòî ñîîòíîøåíèå â 5% ãðàìîòíûõ è 95% íå ñîâñåì-, ìàëî-, ïîëó- è ñîâñåì áåçãðàìîòíûõ - íàøà òðàãåäèÿ î êîòîðîé çíàþò âñå ÷åñòíûå è äóìàþùèå ìåäèöèíñêèå ïðîôåññèîíàëû íàøåé ñòðàíû. Òàêèå êàê Âû ýòî ïîëîæåíèå óñóãóáëÿþò. Äðóãèå æå (êîòîðûõ ê ñ÷àñòüþ íà ôîðóìå ïîäàâëÿþùåå áîëüøèíñòâî) ïûòàþòñÿ ïî ìåðå ñèë äàííîå ïîëîæåíèå èñïðàâèòü. È âïîëíå óñïåøíî, êàê ÿ óæå ñêàçàë. Ñîîòíîøåíèå ìåíÿåòñÿ â ïîñëåäíèå ãîäû â ëó÷øóþ ñòîðîíó.

Èíòåðåñíî, õîòü êòî-íèáóäü, ïóñòü èç Âàøèõ ñòîðîííèêîâ íà ôîðóìå Âàì âåðèò?
ß íàäåþñü, ÷òî äà. È ÿ óâåðåí, ÷òî èç ìîèõ ñòîðîííèêîâ íèêòî íå âåðèò Âàì è íå ðàçäåëÿåò Âàøèõ óáåæäåíèé, ÷òî ïîäòâåðæäàåòñÿ îáðàùåííûìè ê Âàì èõ ïîñòàìè. Ìíå ïîêà íà íåïðàâäó èëè çàáëóæäåíèÿ ìîè êîëëåãè íå óêàçûâàëè. Áóäó âñåãäà ðàä óñëûøàòü êðèòè÷åñêèå çàìå÷àíèÿ îò íèõ.

Êîììåíòàðèè ê ñîîáùåíèþ:
áðóêñà îäîáðèë(à): ìíå ïîíðàâèëîñü
  #19  
Ñòàðûé 28.09.2003, 17:06
Àâàòàð äëÿ Vladlen
Vladlen Vladlen âíå ôîðóìà
Ïîñòîÿííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 25.05.2003
Ãîðîä: Israel
Ñîîáùåíèé: 413
Vladlen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåVladlen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåVladlen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåVladlen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåVladlen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåVladlen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
ÏÎÍÅÄÅËÜÍÈÊ ÍÀ×ÈÍÀÅÒÑß Â ÑÓÁÁÎÒÓ

"...Ðîâíî â òðè ÷àñà, â ñîîòâåòñòâèè ñ òðóäîâûì çàêîíîäàòåëüñòâîì, ïðèíåñ êëþ÷è äîêòîð íàóê Àìâðîñèé Àìáðóàçîâè÷ Âûáåãàëëî. Îí áûë â âàëåíêàõ, ïîäøèòûõ êîæåé, â ïàõó÷åì èçâîç÷èöêîì òóëóïå, èç ïîäíÿòîãî âîðîòíèêà òîð÷àëà âïåðåä ñåäîâàòàÿ íå÷èñòàÿ áîðîäà. Âîëîñû îí ñòðèã ïîä ãîðøîê, òàê ÷òî íèêòî íèêîãäà íå âèäåë åãî óøåé.

– Ýòà... – ñêàçàë îí, ïðèáëèæàÿñü. – Ó ìåíÿ òàì, ìîæåò, ñåãîäíÿ êòî âûëóïèòñÿ.  ëàáîðàòîðèè, çíà÷èòü. Íàäî áû, ýòà, ïðèñìîòðåòü. ß åìó òàì çàïàñîâ íàëîæèë, ýòà, õëåáöà, çíà÷èòü, áóõàíîê ïÿòü, íó òàì îòðóáåé ïàðåíûõ, äâà âåäðà îáðàòó. Íó, à êàê âñå, ýòà, ïîåñò, êèäàòüñÿ íà÷íåò, çíà÷èòü. Òàê òû ìíå, ìîí øåð, òîãî, áðÿêíè, ìèëûé.

Îí ïîëîæèë ïåðåäî ìíîé ñâÿçêó àìáàðíûõ êëþ÷åé è â êàêîì-òî çàòðóäíåíèè îòêðûë ðîò, óñòàâÿñü íà ìåíÿ. Ãëàçà ó íåãî áûëè ïðîçðà÷íûå, â áîðîäå òîð÷àëî ïøåíî.

– Êóäà áðÿêíóòü-òà? – ñïðîñèë ÿ.

Î÷åíü ÿ åãî íå ëþáèë. Áûë îí öèíèê, è áûë îí äóðàê. Ðàáîòó, êîòîðîé îí çàíèìàëñÿ çà òðèñòà ïÿòüäåñÿò ðóáëåé â ìåñÿö, ìîæíî áûëî áû ñìåëî íàçâàòü åâãåíèêîé, íî íèêòî åå òàê íå íàçûâàë – áîÿëèñü ñâÿçûâàòüñÿ. Ýòîò Âûáåãàëëî çàÿâëÿë, ÷òî âñå áåäû, ýòà, îò íåóäîâîëüñòâèÿ ïðîèñòåêàþò è åæåëè, çíà÷èòü, äàòü ÷åëîâåêó âñå – õëåáöà, çíà÷èòü, îòðóáåé ïàðåíûõ, – òî è áóäåò íå ÷åëîâåê, à àíãåë. Íåõèòðóþ ýòó èäåþ îí ïðîáèâàë âñÿ÷åñêè, ðàçìàõèâàÿ òîìàìè êëàññèêîâ, èç êîòîðûõ ñ íåîïèñóåìûì ïðîñòîäóøèåì âûäèðàë ñ êðîâüþ öèòàòû, íåùàäíî îïóñêàÿ è âûìàðûâàÿ âñå, ÷òî åìó íå ïîäõîäèëî.  ñâîå âðåìÿ Ó÷åíûé ñîâåò äðîãíóë ïîä íàòèñêîì ýòîé íåóäåðæèìîé, êàêîé-òî äàæå ïåðâîáûòíîé äåìàãîãèè, è òåìà Âûáåãàëëû áûëà âêëþ÷åíà â ïëàí. Äåéñòâóÿ ñòðîãî ïî ýòîìó ïëàíó, ñòàðàòåëüíî èçìåðÿÿ ñâîè äîñòèæåíèÿ â ïðîöåíòàõ âûïîëíåíèÿ è íèêîãäà íå çàáûâàÿ î ðåæèìå ýêîíîìèè, óâåëè÷åíèè îáîðà÷èâàåìîñòè îáîðîòíûõ ñðåäñòâ, à òàêæå î ñâÿçè ñ æèçíüþ, Âûáåãàëëî çàëîæèë òðè ýêñïåðèìåíòàëüíûå ìîäåëè: ìîäåëü ×åëîâåêà, íåóäîâëåòâîðåííîãî ïîëíîñòüþ, ìîäåëü ×åëîâåêà, íåóäîâëåòâîðåííîãî æåëóäî÷íî, è ìîäåëü ×åëîâåêà, ïîëíîñòüþ óäîâëåòâîðåííîãî. Ïîëíîñòüþ íåóäîâëåòâîðåííûé àíòðîïîèä ïîñïåë ïåðâûì – îí âûâåëñÿ äâå íåäåëè íàçàä. Ýòî æàëêîå ñóùåñòâî, ïîêðûòîå ÿçâàìè, êàê Èîâ, ïîëóðàçëîæèâøååñÿ, ìó÷èìîå âñåìè èçâåñòíûìè è íåèçâåñòíûìè áîëåçíÿìè, íåâåðîÿòíî ãîëîäíîå, ñòðàäàþùåå îò õîëîäà è îò æàðû îäíîâðåìåííî, âûâàëèëîñü â êîðèäîð, îãëàñèëî èíñòèòóò ñåðèåé íå÷ëåíîðàçäåëüíûõ æàëîá è èçäîõëî. Âûáåãàëëî òîðæåñòâîâàë. Òåïåðü ìîæíî áûëî ñ÷èòàòü äîêàçàííûì, ÷òî åæåëè ÷åëîâåêà íå êîðìèòü, íå ïîèòü, íå ëå÷èòü, òî îí, ýòà, áóäåò, çíà÷èòü, íåñ÷àñòëèâ è äàæå, ìîæåò, ïîìðåò. Êàê âîò ýòîò ïîìåð. Ó÷åíûé ñîâåò óæàñíóëñÿ. Çàòåÿ Âûáåãàëëû îáîðà÷èâàëàñü êàêîé-òî æóòêîé ñòîðîíîé. Áûëà ñîçäàíà êîìèññèÿ äëÿ ïðîâåðêè ðàáîòû Âûáåãàëëû. Íî òîò, íå ðàñòåðÿâøèñü, ïðåäñòàâèë äâå ñïðàâêè, èç êîèõ ñëåäîâàëî, âî-ïåðâûõ, ÷òî òðîå ëàáîðàíòîâ åãî ëàáîðàòîðèè åæåãîäíî âûåçæàþò ðàáîòàòü â ïîäøåôíûé ñîâõîç, è, âî-âòîðûõ, ÷òî îí, Âûáåãàëëî, íåêîãäà áûë óçíèêîì öàðèçìà, à òåïåðü ðåãóëÿðíî ÷èòàåò ïîïóëÿðíûå ëåêöèè â ãîðîäñêîì ëåêòîðèè è íà ïåðèôåðèè. È ïîêà îøåëîìëåííàÿ êîìèññèÿ ïûòàëàñü ðàçîáðàòüñÿ â ëîãèêå ïðîèñõîäÿùåãî, îí íåòîðîïëèâî âûâåç ñ ïîäøåôíîãî ðûáîçàâîäà (â ïîðÿäêå ñâÿçè ñ ïðîèçâîäñòâîì) ÷åòûðå ãðóçîâèêà ñåëåäî÷íûõ ãîëîâ äëÿ ñîçðåâàþùåãî àíòðîïîèäà, íåóäîâëåòâîðåííîãî æåëóäî÷íî. Êîìèññèÿ ïèñàëà îò÷åò, à èíñòèòóò â ñòðàõå æäàë äàëüíåéøèõ ñîáûòèé. Ñîñåäè Âûáåãàëëû ïî ýòàæó áðàëè îòïóñêà çà ñâîé ñ÷åò..."

Àðêàäèé Ñòðóãàöêèé, Áîðèñ Ñòðóãàöêèé

Êîììåíòàðèè ê ñîîáùåíèþ:
Dobro îäîáðèë(à):
  #20  
Ñòàðûé 28.09.2003, 18:12
Zhivov Zhivov âíå ôîðóìà
Âåòåðàí ôîðóìà
      
 
Ðåãèñòðàöèÿ: 20.08.2001
Ñîîáùåíèé: 3,792
Zhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Âñå èìåííî òàê äî ñèõ ïîð è èäåò, Âëàäëåí.
  #21  
Ñòàðûé 28.09.2003, 19:13
V. ZAITSEV V. ZAITSEV âíå ôîðóìà Ïîë ìóæñêîé
çàáàíåí
      
 
Ðåãèñòðàöèÿ: 25.07.2001
Ñîîáùåíèé: 3,330
V. ZAITSEV
Ñóäèòñÿ ñ Âàìè Àëåêñåé Âèêòîðîâè÷, ÿ íå áóäó, à óäàëÿòü Âàøè ñîîáùåíèÿ - çàïðîñòî. Ìîæíî ñïîðèòü ñ äîêàçàòåëüñòâàìè, à íå ñ ëîæüþ, âûñîñàííîé èç ïàëüöà. Åù¸ ðàç, åñëè Âû, êàê è Å.Å.Ñòóäåíöîâ íå ïðèâåäóò ïîäòâåðæäåíèÿ ñâîèì óòâåðæäåíèÿì, î êîòîðûõ íåñêîëüêî ðàç âàñ ñïðàøèâàë, âàøè èíñèíóàöèè áóäóò èç ýòîé äèñêóññèè óäàëåíû. ×òî äî ñàìîìíåíèÿ, òî ëþáîìó àêàäåìèêó äî Âàñ äàëåêî, à êàê Âû óìååòå èçâîðà÷èâàòüñÿ, êîãäà äàåòå «ïåíêè» ïî ýëåìåíòàðíûì âåùàì è ïî ñâîåé ñïåöèàëüíîñòè, ìîæíî óâèäåòü õîòÿ áû â http://forums.rusmedserv.com/showthr...&threadid=5722
È ïîñëå ýòîãî Âàì íåÿñíî ïî÷åìó ÿ íå ïîøåë áû ê Âàì ëå÷èòüñÿ è çíàêîìûì íå ðåêîìåíäîâàë? Ïðîñòî ÿ Âàì íå âåðþ íè êàê ÷åëîâåêó, íè êàê âðà÷ó.
Ïîâîäó «ñ÷èòàåòñÿ îòïåòûì øàðëàòàíñòâîì êàê â ÑØÀ, òàê è â Åâðîïå» – ýòî íå áîëåå, ÷åì Âàøå ñòðàñòíîå æåëàíèå. Åù¸ ðàç, êîìó èíòåðåñíî, ìîãóò ïîñìîòðåòü àâòîðîâ, ó÷àñòâóþùèõ â êîíôåðåíöèÿõ ïî îçîíîòåðàïèè, êîòîðûå ÿ ïðèâîäèë. Ýòî ïðîô. è äîêòîðà ðàçëè÷íûõ ñòðàí Åâðîïû è îòíþäü íå èç àëüòåðíàòèâíûõ êëèíèê. Çäåñü ìíå íåîäíîêðàòíî ññûëàëèñü íà ïîñëåäíþþ êíèãó ïðîô. V.Bocci, äèðåêòîðà êðóïíîãî èíñòèòóòà, ïî÷åòíîãî ÷ëåíà ìíîæåñòâà ìåäèöèíñêèõ ñîîáùåñòâ, ãäå îí äåñêàòü êðèòèêóåò îçîíîòåðàïèþ. ß ïðèâåë (äâàæäû) ïðåäèñëîâèå ê ýòîé êíèãå, ãäå åñòü ñëîâà: Ozone is now considered a real drug and, after reacting with body fluids, releases messengers and activates several mechanisms which are able to elicit multiple biological effects. Îçîí òåïåðü ðàññìàòðèâàåòñÿ ÐÅÀËÜÍÛÌ ëåêàðñòâåííûì ñðåäñòâîì, è ïîñëå åãî ðåàêöèè ñ æèäêèìè ôàçàìè îðãàíèçìà, îáðàçóþòñÿ ìåòàáîëèòû, ñ ìíîæåñòâåííûì áèîëîãè÷åñêèì äåéñòâèåì.
We could soon have a simple and inexpensive tool to restore health in millions of patients.
Ìû ìîãëè áû ñêîðî èìåòü ïðîñòóþ è íåäîðîãóþ òåðàïèþ, ÷òîáû âîññòàíîâèòü çäîðîâüå ìèëëèîíîâ ïàöèåíòîâ.
Îïïîíåíòû, êàê â ðîò âîäû íàáðàëè. È êîìó ïîñëå ýòîãî íå ïîíÿòíî, ÷òî èìè äâèæåò?
  #22  
Ñòàðûé 28.09.2003, 22:38
Zhivov Zhivov âíå ôîðóìà
Âåòåðàí ôîðóìà
      
 
Ðåãèñòðàöèÿ: 20.08.2001
Ñîîáùåíèé: 3,792
Zhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ñóäèòñÿ ñ Âàìè Àëåêñåé Âèêòîðîâè÷, ÿ íå áóäó, à óäàëÿòü Âàøè ñîîáùåíèÿ - çàïðîñòî.
ß ñ âàìè è íå ñîáèðàëñÿ ñóäèòüñÿ, ñ ÷åãî âû âçÿëè. Óäàëÿòü áóäåòå? Äà ïîæàëóéñòà! Îïóáëèêóåì òî æå ñàìîå â ñàìîì ïîïóëÿðíîé äèñêóññèè ôîðóìà ïîñâÿùåííîé ðîññèéñêîìó ìåäøàðëàòàíñòâó, ò.å. â ÷àñòíîñòè è âàì ìèëîñòèâûé ãîñóäàðü.

 âûáðàííîì Âàìè ìåñòå íàøèõ äèñêóññèé ÿ ÷åñòíî è îòêðûòî ïðèçíàë ñâîþ îøèáêó (åñëè Âû î ñîñòàâå ïîäàãðè÷åñêèõ îòëîæåíèé) è íå èçâîðà÷èâàëñÿ. Âîò òîëüêî Âû, âîîáùå íè÷åãî íå ïîíèìàþùèé â êëèíè÷åñêèõ ìàòåðèÿõ, íè ðàçó ñâîèõ îøèáîê íå ñêëîííû áûëè ïðèçíàòü. Íó ëàäíî ÿ âàì íå óêàç. Òàê Âû äàæå óâàæàåìóþ âàìè (òàê Âû ïèñàëè) Ãàëèíó Àôàíàñüåâíó òîæå èçâîëèëè èãíîðèðîâàòü.

Ïðîñòî ÿ Âàì íå âåðþ íè êàê ÷åëîâåêó, íè êàê âðà÷ó.
À ÿ âàì. È íå òîëüêî ÿ, à è òå ìíîãèå âðà÷è, ê êîòîðûì Âû áû ïîñîâåòîâàëè îáðàòèòüñÿ ñâîèì äðóçüÿì. È ïî÷åìó ìû äîëæíû âåðèòü òîìó, ÷òî ïóáëèêóåòå/öèòèðóåòå Âû? Ýòî âåäü â îñíîâíîì âûäåðæêè èç âòîðî- è òðåòüåñòåïåííûõ ìåäèöèíñêèõ æóðíàëîâ è òîãî õóæå è ãîðàçäî ÷àùå ñ ðåêëàìíûõ ñàéòîâ è ÑÌÈ. Óâàæàåìûé êîëëåãà Ñòóäåíöîâ ïðèâåë èñêëþ÷èòåëüíî ññûëêè èç áîëåå íàäåæíûõ èñòî÷íèêîâ è âñå îíè ãîâîðÿò î òîì, ÷òî ÎÒ êàê ìèíèìóì ìåòîä ýêñïåðèìåíòàëüíûé è êàê ìàêñèìóì øàðëàòàíñòâî. ×òî Åâãåíèé âàì äîëæåí åùå ïîäòâåðæäàòü? Åãî ïîñòû ñîñòîÿò ïî÷òè öåëèêîì èç ññûëîê.

×åìó ìîæíî âåðèòü æåëåçîáåòîííî, òàê ýòî òîìó, ÷òî íè îäèí êîíñåíñóñ ñïåöèàëèñòîâ, ïðîôàññîöèàöèÿ è ò.ä. è ò.ï. îáúåäèíåíèÿ ÂÐÀ×ÅÉ âîîáùå íå ñ÷èòàþò îçîíîòåðàïèþ ìåòîäîì ëå÷åíèÿ ÷åãî-ëèáî. Âû è â ýòî íå âåðèòå?????????
Òîãäà ÿ ìîãó íå ïîâåðèòü, ÷òî Âàñ çîâóò Âëàäèìèð ßêîâëåâè÷ à ìåíÿ Àëåêñåé Âèêòîðîâè÷. Òàê âîò åñëè äî ñèõ ïîð íèêåì è íèãäå îôèöèàëüíî (íå â åäèíè÷íûõ ðàáîòàõ ïèëîòíîãî õàðàêòåðà è íå â ìíîãèõ äðóãèõ èññëåäîâàíèÿõ áåñïðåäåëüíî íèçêîãî óðîâíÿ äîêàçàòåëüíîñòè) ÎÒ íå ïðèçíàíà ýôôåêòèâíûì ìåòîäîì ëå÷åíèÿ - çíà÷èò ýòî ïðîñòî ïîêà ÝÊÑÏÅÐÈÌÅÍÒ!!! Ýòî ÷òî îïÿòü íå óáåäèòåëüíî çâó÷èò??? ×åãî óæ ïðàâäèâåå ïî ìîåìó! Òàê êàêèõ äîêàçàòåëüñòâ îò íàñ Âû åùå òðåáóåòå? Ìåòîä ñ÷èòàåòñÿ âî âñåì ìèðå ýêñïåðèìåíòàëüíûì, çíà÷èò âíå ìåäèöèíû. È òî, ÷òî â Ðîññèè åãî èñïîëüçóþò áåç ñîîòâåñòâóþùåãî èíôîðìèðîâàíèÿ ïàöèåíòîâ (ñì. î íåîáõîäèìîñòè ýòîãî öèòàòàó èç Bocci, êîòîðóþ ïðèâåë Å. Ñòóäåíöîâ) - ýòè÷åñêîå, à äëÿ íîðìàëüíîé ñòðàíû ïðîñòî óãîëîâíîå ïðåñòóïëåíèå. Çà ÷òî âî Ôëîðèäå è ñóäèëè æóëèêîâ îò îçîíà.

Îçîí òåïåðü ðàññìàòðèâàåòñÿ ÐÅÀËÜÍÛÌ ëåêàðñòâåííûì ñðåäñòâîì, è ïîñëå åãî ðåàêöèè ñ æèäêèìè ôàçàìè îðãàíèçìà, îáðàçóþòñÿ ìåòàáîëèòû, ñ ìíîæåñòâåííûì áèîëîãè÷åñêèì äåéñòâèåì.
Çíàåòå äðàæàéøèé, ÐÅÀËÜÍÛÅ ëåêàðñòâà äëÿ òîãî è ñîçäàþò, ÷òîáû îíè áûëè ïðåïàðàòàìè âûáîðà â ëå÷åíèè çàáîëåâàíèé. Åñëè îçîí íå ÿâëÿåòñÿ ïðåïàðàòîì âûáîðà äëÿ ëå÷åíèÿ ÷åãî ëèáî, çíà÷èò ðåàëüíîñòü åãî êàê ëåêàðñòâà åùå íèêåì íå óñòàíîâëåíà.

Ìû ìîãëè áû ñêîðî èìåòü ïðîñòóþ è íåäîðîãóþ òåðàïèþ, ÷òîáû âîññòàíîâèòü çäîðîâüå ìèëëèîíîâ ïàöèåíòîâ.
È áóäåì èìåòü, òîëüêî ýòà òåðàïèÿ ÿâíî íå áóäåò ïðîñòîé è íåäîðîãîé äà è ê îçîíó íà 300% óâåðåí íå áóäåò èìåòü íè ìàëåéøåãî îòíîøåíèÿ.
  #23  
Ñòàðûé 28.09.2003, 23:54
V. ZAITSEV V. ZAITSEV âíå ôîðóìà Ïîë ìóæñêîé
çàáàíåí
      
 
Ðåãèñòðàöèÿ: 25.07.2001
Ñîîáùåíèé: 3,330
V. ZAITSEV
1. Ïîñëåäíèé ðàç, Àëåêñåé Âèêòîðîâè÷, Âû áóäåòå ïðèâîäèòü ïîäòâåðæäåíèå ìèôè÷åñêèõ áîëüíûõ, îçîíîòåðàïåâòîâ, íà êîòîðûå Âû ññûëàëèñü?
2. Â äèñêóññèè http://forums.rusmedserv.com/showthr...&threadid=5722
Âû êàê âñåãäà ñ íàãëîâàòîé íðàâîó÷èòåëüíîñòüþ ìíå âòîëêîâûâàëè:
«Âëàäèìèð ßêîâëåâè÷! Âû âèäèìî òàê âîëíóåòåñü, êîãäà â î÷åðåäíîé ðàç ñàäèòåñü â ëóæó, ÷òî íå îáðàùàåòå âíèìàíèå íà òî, ÷òî ïèøóò ïàöèåíòû. notik ìíå ñîîáùèëà ïî ïîâîäó ñïåðìîãðàììû åå ìóæà: Âû ïðàâèëüíî ïîíÿëè: â 1 ìë. - 60 ìëí. 52% æèâûõ (÷èòàé ïîäâèæíûõ), 10%-äâèãàþùèõñÿ íà ìåñòå, îñòàëüíûå -íåïîäâèæíû. Âàì îñòàåòñÿ ñîïîñòàâèòü ýòîò ðåçóëüòàò ñ ÂÎÇîâñêîé íîðìîé ñïåðìîãðàììû, êîòîðóþ ÿ ïðèâåë. È åñëè åñòü ãëàçêè - âñå ïîéìåòå».
Íî êàê îêàçàëîñü â ëóæó ñåëè Âû, òàê êàê æèâûå è àêòèâíîïîäâèæíûå ñïåðìàòîçîèäû ÄÂÅ ÁÎËÜØÈÅ ÐÀÇÍÈÖÛ, æèâûõ ìîæåò áûòü ïîëíî, à ïîëíîöåííûõ íóëü è íàïûùåííîìó óðîëîãó ñòûäíî ýòî íå çíàòü.
3. Ïîñëåäíèå ôðàçû î ïåðñïåêòèâàõ ÎÒ ïðèíàäëåæàò íå ìíå.  ñâîåì ðâåíèè, Âû îïðîâåðãàåòå è Ðîññèéñêèõ àêàäåìèêîâ è âåäóùèõ çàðóáåæíûõ ñïåöèàëèñòîâ, ïëîòíî ñâÿçàííûõ ñ ìåä. îçîíîì íå îäèí ãîä. Ïðè÷åì î òåðàïèè, î êîòîðîé íå èìååòå íè ìàëåéøåãî ïðåäñòàâëåíèÿ. Îáúÿñíÿòü ÷åëîâåêó ñ ìàíèåé âåëè÷èÿ, ÷òî íå åìó âûñêàçûâàòüñÿ ïî 300% óâåðåííîñòè, áåññìûñëåííî.
4. Ïðèâîæó ðàáîòû ïî ÎÒ òîëüêî ïðè îäíîé èç ïàòîëîãèé, óïîìèíàåìûõ Å.Å.Ñòóäåíöîâûì. Áûë áû èçóìëåí, åñëè êòî-íèáóäü èç îïïîíåíòîâ èõ ïîñìîòðèò. Äëÿ êðèòèêè (òî÷íåå îõàèâàíèÿ) ïðèíÿòîé íà ôîðóìå, îçíàêîìëåíèå ñ ìàòåðèàëîì ïî ïðåäìåòó êðèòèêè ñîâñåì íè ê ÷åìó.


ID 24
CT-Guided intraforaminal oxygen-ozone therapy in lumbar disc herniation
M. Bonetti, B. Cotticelli, F. Albertini, L. Valdenassi*, and P. Richelmi*Servizio di Neuroradiologia Istituto Policlinico San Donato Milanese, *
Istituto di Farmacologia II - Università di Pavia, Milano/Pavia, Italy

Background: In recent years, there have been an increasing number of reports on the use of oxygen-ozone therapy in disc-root conflict caused by disc herniation. In addition, different routes of administration have been devised to inject the gas mixture: the so-called classical technique of paraspinal intramuscular injection, endoscopic or CT-guided intraforaminal administration and direct intradiscal infiltration.
Materials and methods: This paper assesses the therapeutic efficacy of CT-guided intraforaminal injection of an oxygen-ozone mixture in patients with disc-root pain caused by lumbar disc herniation. We have treated 368 patients between October 1998 and December 2002. A complete resolution of symptoms was achieved in 311 cases (84.5 %). On enrolment, a clinical chart was prepared specifying name, date of birth, date of enrolment, date of first treatment and clinical information on type of pain, irradiation, possible paraesthesias, Lasègue’s sign, degree of sensitivity, lower limb reflexes, plantar and dorsal extension of the foot and dorsal extension of the big toe. All patients had undergone CT or MR investigation with a diagnosis of non-calcified disc herniation. All patients with multiple hernias and those who had undergone surgery were excluded. The number of treatments was also specified ranging from a minimum of one session to a maximum of four. CT scan was performed at the outset to establish the point of injection at skin level and then the distance between this point and the root foramen was measured. Local anaesthesia was given by ethyl chloride spray. CT scans were then used to check the correct positioning of the needle whose tip must be 4-5 mm from the foraminal region. Three cc of oxygen-ozone mixture at 25mg/ml were injected; and the needle was then withdrawn by a few mm before injecting 7-8 cc of the gas mixture into the intervertebral joint. Another CT scan was then performed to ascertain the correct distribution of the oxygen-ozone mixture. Patients were kept under clinical observation for two hours and then discharged.
Results: The clinical benefit of treatment was immediate. The mechanism of action of oxygen-ozone therapy remains unsettled. The treatments may have a direct effect on the mucopolysaccharide chains in the nucleus pulposus, leading to oxidation and release of water molecules resulting in a mechanical resolution of disc-root conflict.
Many indirect mechanisms are also known including anti-inflammatory, analgesic and eutrophic effects with a reduction in disc degeneration and decongestion of the nerve roots.
Conclusion: We conclude that CT-guided oxygen-ozone injection is a highly effective treatment for lumbar disc herniation.

ID 74
Spinal segmental stabilization and oxygen-ozone therapy for lumbar discal hernia
Controlled, multicentric, randomised study.
preliminary resultsM. Monticone, A. Barbarino, R. Garri, L. Valdenassi, P. Richelmi, F. Bertè, and A. Moschi
Surgery Department, Physiotherapy and Rehabilitation Section, University of Pavia , Pavia, Italy
Background: Discal Hernia is considered one of the most causes of acute and subacute lumbar pain, accompanied by a strong decrease in the quality of life.
Materials and methods: Controlled, multicentric, randomised trial. 20 patients were chosen with an average age of 43.
Criteria of inclusion: no cognitive deficiencies, clinical and neuroradiological signs of Lumbar Discal Hernia, algia present for between two and six months, no response to medication or physiotherapy.
1st group(10 subjects): treatment with Oxygen-ozone Therapy and spinal segmental stabilization exercises.
2nd group(10 subjects): Oxygen-ozone Therapy. Both groups: 8 fortnightly sessions and the administration of Ozone by means of paravertebral penetration at a concentration of 20 m/ml.
Before the start, at the end and at the three-month follow-up, every patient was assessed for: pain at rest (VAS), pain during movement (VAS), articular movements.
Results: Analysis of the results showed a reduction in pain and an increase in flexibility, in the 1st group (p<0.03) and in the 2nd group (p<0.05). At the follow-up the significance remained at (p<0.05) in the 1st group. Comparison showed the results to be in favour of the first group (p<0.01).
Conclusions: Spinal segmental stabilization exercises accompanied by Oxygen-ozone Therapy are shown to have positive results. Our study, although preliminary, has brought to light the concrete possibility of functionally managing pain caused by Lumbar Hernia, at both acute and subacute stages, thus allowing the doctor and physiotherapist to use rehabilitation techniques based on accurate clinical reasoning and providing the patient with the possibility of daily self-treatment.

ID 99
Ozygen-ozone therapy in disc-root compression pain syndrome: comparison with other methods
A. Gjonovic, E. Montimara, T. Girotto, P. Richelmi.*, and L. Valdenassi*
OU Pain and Palliative Therapy, ASL 16, Regione Veneto, Dpt. Of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy
Background: Oxygen-ozone therapy by paraspinal intramuscular injection is a method used in recent years for the treatment of sciatica with effective results.
We assessed effectiveness of this therapy in comparison with peridural cortisone administration and paraspinal intramuscular treatment with only local anaesthetic.
Material and methods: We studied 90 patients with lumbar pain and sciatica relating to disc-root compression; they were divided in 3 groups as much as possible homogeneous for initial intensity pain, for his irradiation and hernial compression seat. The first group was treated with oxygen-ozone (paraspinal bilateral injection with 15-20 ml of gas for side at 15 mg/ml concentration in 8 sessions for 20 days). The second group of patients were treated with 3 peridural injections (15 ml physiological solution with desamethasone phosphate 8 ml) always for 20 days. The last group was treated with bilateral injection of 10 mg bupivacaine 0,25% in the same seats of oxygen-ozone injection.
Results: Analysis of results has demonstrated a success percentage of 75% in oxygen-ozone group, of 55% in peridural cortisone group and 25% in local anaesthetic group.
Conclusions: This confirm a real clinical effectiveness of oxygen-ozone therapy in lumbar pain and sciatica relating to disc hernia especially in comparison with the third group; peridural cortisone administration is real effective but in lower percentage in comparison with group treated with oxygen-ozone.
  #24  
Ñòàðûé 28.09.2003, 23:56
V. ZAITSEV V. ZAITSEV âíå ôîðóìà Ïîë ìóæñêîé
çàáàíåí
      
 
Ðåãèñòðàöèÿ: 25.07.2001
Ñîîáùåíèé: 3,330
V. ZAITSEV
Ïðîäîëæåíèå.

ID 105
Follow-up disc-root compression and post-surgical radiculopathies with paravertebral oxygen-ozone
L. Valdenassi, G. Nardelli, P. Richelmi, and F. Bert&egrave;
Dept. of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy
Background: Disc-root compression is increasingly treated by oxygen-ozone injections following the positive outcome of therapy reported in the literature. The aim of the current study is the presentation of the effects of oxygen-ozone therapy relating to a clinical follow-up.
Materials and methods: We assessed the validity of this therapy in a prospective study on 240 patients (two groups according to etiopathogenesis): group 1: 188 patients with herniated disc and disc-root compression, group 2: 52 patients with radiculopathy related to post-surgical fibrosis. All patients have received paravertebral injections with oxygen-ozone in 10 sessions. Outcome was analysed with clinical test, subjective evaluation and TC. All specifics symptoms were examinated after therapy, then 6 months later and so again 1 year and 4 years later.
Results: Were obtained excellent results in the first group: 95 patients (51%) have complete or marked resolution of symptoms; goods results in the second: 65 (35%) with major reduction of symptoms and little or no benefit 28 (15%).
Among second group the results were not as good: excellent results were obtained in 17 patients (33%), good in 15 (29%). Whereas negative results in 18 patients (35%).After 1 year results were the same, only 2 patients of the first group and 5 of the second have relapse of symptoms. After 4 years 6 patients of the first group and 5 of the second demonstrated relapse of symptoms.
Conclusions: According to analysis of follow-up, oxygen-ozone therapy is an effective treatment for disc-root compression and post-surgical radiculopathy also after a long time.

ID 167
Intrasacral epidural injection with oxygen-ozone for the treatment of low back pain. Comparison and evaluation with other techniques and rehabilitation and return to work.
I. Mattozzi, Gp. Laurini, G. Muzzi,M. Franzini*, and A. Bigiotti
Department of Anesthesia, Reanimation ASL Viterbo, Italy; *T. Oxygen Ozone Therapy University of Pavia, Pavia, Italy
Background: Low back pain caused by hernia and/or protrusion of the disks L4-L5 and or L5 S1 is among the most frequent causes of abstention from work in Western Countries.The caudal epidural block is often used in the treatment of chronic pain.
Materials and methods: We administered an intrasacral epidural injection to a group of patients, all of whom were free-lance workers affected by low back pain, using a mixture of 20 ml of O2 O3 to the concentration of 20 µgr/ml by means of the medical device Multiossigen Medical 99 IR, ISO 9002. This methodology has been compared with others and evaluation has been made in terms of rehabilitation and a speedy return to work.
Result: The Intrasacral epidural injection with O2-O3 has shown a greater effect on the pain and a greater effectiveness in allowing the patient to return to his normal working activity.
Conclusions: In experienced hands, this easily used technique which carries no risk of neurological damage, represents a valid opportunity for the patient to return to his work-place in the briefest time possible.


ID 173
Postural diagnosis importance in the root – disc conflict pathology
L. Mascolo, A. Sammartino, M. Luongo, V. Villani, C. Cipollaro, and C. Luongo
Clinica Villa dei Fiori, Serv. Di terapia Iperbarica e Ozonoterapia, Acerra (Naples), Italy
In the past 15 years about 10% of patients suffering from root – disc conflict pathology didn’t respond positively to an infiltration therapy based on oxygen-ozone mixture administered 2 times a week.
Today we can verify, using a complete examination which includes bone and articular system, muscular, tendineous, nervous and vascular systems, that the painful symptoms of the root – disc conflict pathologies can be due or sustained by pathologies of the temporal-mandible joint and/or changes of the plantar arch support.
The above-mentioned examination consists of the step emission of electric impulses (6v) from electrodes applied on the patient’s head, hands and feet.
A dedicated software is able to collect and analyze the impulses steps pattern. The software is able to produce a diagnosis based on a known pattern similarity.
Using this system we can verify that many pathologies of the loin-sacral area are caused by a postural ascending change and/or a so-called descending change of the temporal-mandible joint.
The system allows the definition of the most correct dosage of the oxygen-ozone mixture we have to seep through in the areas indicated by the system itself.

Conclusion: This diagnostic - therapeutic system, used on about one hundred patients so far, let us observe a disappearance or a significant reduction of the viral charge in about 90% of treated patients.

ID 197
Chemodiskolysis and periradicular and periganglionic infiltration with oxygen-ozone in disk herniation
C. Andreula1, M. Leonardi2, and M. Bonetti3
1Neuroradiology, a.o. Policlinico-consorziale, Anthea Hospital, Bari, Italy; 2Neuroradiology a.o. Bellaria, Bologna, Italy; 3Neuroradiology Gruppo San Donato” (Istituto Clinico Citt&agrave; di Brescia,Iistituto Policlinico San Donato Milanese), Italy
Background: The success in surgically operated patients for lumbar-sacral disk herniations is about 80-85%, for the Failed Back Surgery Sindrome with severe symptoms in 20%. For these results new techniques (spinal procedures) were considered to reduce the surgical approach and the undesired infectious complications. We report our experience with chemodiskolysis with oxygen-ozone
Material, method, results: In a 2-years period we treated more than 1000 patients by Chemiodiskolysis and periradicular and paraganglionic infiltration with Oxygen-ozone mixture, excellent and good results in 74% and unsatisfactory (bad) results in 26%. We do not report any complications: diskitis may occur but strict surgical asepsis of the procedure will avoid it. The patients who fail to benefit from this percutaneous treatment are referred to surgery without any negative effects.
Conclusions: The mechanisms of ozone action are: 1. Reduction of the volume of the nucleus pulposus, 2. Reduction of the inflammation for oxidative action on the pain mediators, 3. Better microcirculation: the sensitive nervous roots are sensible to hypossia
1. .
The good results achieved using this techniques, with very low risk of complications and very low cost, suggest chemodiskolysis and periradicular and periganglionic infiltration with oxygen-ozone mixture as the procedure of choice, in patients with sciatica for contained disk herniation without any motor symptoms.

ID 198
Combined effect of O2/O3 and GPR in treatment of lumbar disc herniation. Anatomical, clinical, and patient-self-report evaluation
D. Apuzzo1, M. Franzini2, L. Di Lucente3, M.C. Gioia3, A. Cerasa3, U. Sabatini3, and A. Castriota-Scanderbeg3
2Dept. of Physical Medicine and Rehabilitation, University di Pavia, 1Studio Medico Apuzzo, Rome, Italy, 3 Fondazione IRCCS Santa Lucia, Rome, Italy
Background: Experimental studies indicate that the O2/O3 increases the micro-vascular activity, induces neo-angiogenesis and facilitates the elimination of toxic metabolite. Global Postural Re-education (GPR) re-equilibrate posture by training the muscles of the spine. We evaluated the anatomical clinical and patient-self-report effects induced by combined O2/O3 and GPR treatment of lumbar disc herniation.
Materials and methods: We studied 40 patients suffering from lumbar disc herniation. They were assessed before and after combined O2/O3 and GPR treatment with MRI, Valleix points, Lasegue test, Role functioning Physical and General Health sub-scales of SF-36 test and numeric-non-verbal scale for pain evaluation. The O2/O3 infiltration and the GPR were repeated for about 22 times at different frequency along 6 months.
Results: Post treatment MRI revealed that 47% of patients had a reduction of the hernia volume. The clinical outcome showed a significant reduction of symptoms (Valleux points p<0.0001 and Lasegue test p<0.001). Mainly each patient had reduction of pain (p<0.0001) and did improve his quality of life (p<0.001) i.e. work or daily activities had been resumed to pre-symptomatical levels.
Conclusions: It has to be point out that the percentage of hernia volume reduction of those patients who underwent any conservative treatment is similar to the percentage reduction we found in our series. Nevertheless, combined O2/O3 and GPR significantly reduce the feeling of pain and do improve the quality of life in these patients.
(Preliminary data of this study have been presented to the ASOO, November 2002, Forte dei Marmi, Italy).
  #25  
Ñòàðûé 28.09.2003, 23:57
V. ZAITSEV V. ZAITSEV âíå ôîðóìà Ïîë ìóæñêîé
çàáàíåí
      
 
Ðåãèñòðàöèÿ: 25.07.2001
Ñîîáùåíèé: 3,330
V. ZAITSEV
Îêîí÷àíèå

ID 202
Clinical experience in the treatment of lumbar and cervical disk disease, knee arthritis and "frozen" shoulder, by injection of an oxygen-ozone mixture
G. Torri, and *F. Vaiano
Orthopedic clinic-Milan University, Milano, Italy; *Member of the National Board of SIOOT, Italy
Background: Ozonetherapy has found many applications in treatment of various orthopedic pathologies, and that's for its poor invasivity, the absence of secondary effects and for the low cost.
Materials and methods: 290 patients ageing between 23-80 years (range:35,5y)of wich 150 men and 140 women, has been treated for different spine disk abnormalities (disk protrusions and contained herniations, 20 ex- truded herniations,32 relapses of disk herniations)in 50 cases joined with asymptomatic spinal canal stenosis or facet joints arthritis.12 patients were treated for cervical spine disk disease, 8 patients for knee arthritis with synovitis and 8 for "frozen" shoulder syndrome. Patients affected by spinal disk disease have been treated for 12 session by two bilateral injections into paravertebral muscles, at the level of the discopathy, with an oxygen-ozone mixture; ozone concentration was of 20mcg/mlo2 for lumbar spine disk disease and of 10mcg/mlo2 for cervical spine. For knee arthritis and "frozen" shoulder, patients were treated with 6-10 injections of an O2-O3 gaseouse mixture (ozone concentration: 10mcg/mlo2)once a week.
Results: global evaluation has shown good and excellent results in 60%of lumbar and cervical disk disease, a mild and subjective improvement in 30% and fair results in 10%of cases. Excellent results were observed in patients treated for knee arthritis, while only poor results in patients affected by "frozen" shoulder.
Conclusion: despite a very high percentage of good result in spinal disk diseases, there is still to be clarified some mechanisms of action of a mixture of o2-o3 on spinal nerve root involvement.
  #26  
Ñòàðûé 29.09.2003, 06:32
E.E. Studentsov E.E. Studentsov âíå ôîðóìà
Çàñëóæåííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 29.06.2003
Ãîðîä: New York, USA
Ñîîáùåíèé: 834
Ñêàçàë(à) ñïàñèáî: 2
Ïîáëàãîäàðèëè 6 ðàç(à) çà 4 ñîîáùåíèé
E.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Óâàæàåìûé Âëàäèìèð ßêîâëåâè÷!
Ìîå ïîñëåäíåå ñîîáùåíèå áûëî àäðåñîâàíî äîêòîðó, íà÷àâøåìó ýòó äèñêóññèþ. Âñòóïàòü ñ Âàìè â î÷åðåäíûå ïðåíèÿ íå âõîäèëî â ìîè íàìåðåíèÿ âñëåäñòâèå èõ ïîëíîé áåñïåðñïåêòèâíîñòè, ÷òî ñòàëî ÿñíî ïîñëå íàøåãî ïðåäûäóùåãî ðàçãîâîðà, êîãäà Âû óøëè îò êîíêðåòíûõ âîïðîñîâ è ïðåäïî÷ëè íàó÷íîé äèñêóññèè ïîïóëÿðèñòè÷åñêèå äåêëàðàöèè ("îñëàâèòü íà ñúåçäå îçîíîòåðàïåâòîâ").  ìîåì ïîíèìàíèè íàó÷íîé äèñêóññèè, â îòëè÷èå îò îáûâàòåëüñêèõ ðàçãîâîðîâ è äåìàãîãè÷åñêèõ ðàññóæäåíèé, ïðèñóùå ñâîéñòâî êîíêðåòíîñòè. Âû íå îòâåòèëè íà áîëüøèíñòâî ìîèõ âîïðîñîâ è íå ïðåäîñòàâèëè ìíå ññûëêè, î êîòîðûõ ÿ Âàñ ïðîñèë.
 ïîñëåäíåì ìîåì ñîîáùåíèè, êàê ïî ìîåìó î÷åâèäíî, ÿ íå âûñêàçûâàë ñâîè ñîáñòâåííûå ñîîáðàæåíèÿ, à èñêëþ÷èòåëüíî öèòèðîâàë äàííûå èç èñòî÷íèêîâ, îòðàæàþùèõ âçãëÿä ìèðîâîãî ìåäèöèíñêîãî ñîîáùåñòâà íà îçîíîòåðàïèþ. Êàêèå äîïîëíèòåëüíûå äîêàçàòåëüñòâà Âû îò ìåíÿ òðåáóåòå, åñëè ñîîáùåíèå ñîcòîÿëî èç ïåðåâîäîâ ïåðâîèñòî÷íèêîâ, ññûëêè íà êîòîðûå äàíû ïîñëå êàæäîé öèòàòû? Äðóãîå äåëî, ÷òî â îòëè÷èå îò Åâðîïû è Àìåðèêè, â Ðîññèè äîñòóï ê ýòèì èñòî÷íèêàì çàòðóäíåí.
Ìîè ÷àñòûå ññûëêè íà V.Bocci ñâÿçàíû ñ òåì, ÷òî áóäó÷è ïðèâåðæåíöåì îçîíîòåðàïèè (ÿ, êñòàòè, íå íàçûâàë åãî îñíîâàòåëåì îçîíîòåðàïèè, à ëèøü ñ÷èòàþ åå íàó÷íûì îòöîì) è ïîñâÿòèâ åé áîëüøóþ ÷àñòü ñâîåé íàó÷íîé êàðüåðû, îí â ñâîèõ ðàáîòàõ ñòðåìèòñÿ ê îáúåêòèâíîñòè. Âñïîìíèòå ïðîöèòèðîâàííûå âûäåðæêè èç åãî ðàáîò:
Bîò ìíåíèå Bocci, âûñêàçàííîå â 1998 ãîäó (Velio Bocci, "Is Ozone Therapy Terapeutic" Prospectives of Biology and Medicine, 42, 1 . Autumn 1998):
"It appears important to emphasize at once that ozone therapy ought to be used ONLY when orthodox medicine is unable to offer a valid treatment. Moreover, some practical reservations remain, and I am not all sure that ozone therapy will be able to acquire a stable position in the medical armamentarium until appropriate investigations are carried out".
 ðàáîòå "Has ozone therapy a future in medicine?" , Br. J. Biomed. Sci. 1999, Bocci ïèøåò: "...attention should be concentrated on the following points: ...evaluation of any possible long term toxicity,...randomized, double-blind clinical studies using either O2-O3 or O3 alone versus conventional treatments, with assessment of long term follow up..."
ÏÅÐÅÂÎÄ: "Âàæíî ïîä÷åðêíóòü, ÷òî îçíîòåðàïèÿ äîëæíà èñïîëüçîâàòüñÿ òîëüêî â òåõ ñëó÷àÿõ, êîãäà îðòîäîêñàëüíàÿ ìåäèöèíà íå ìîæåò ïðåäëîæèòü ýôôåêòèâíîå ëå÷åíèå. Áîëåå òîãî, îñòàþòñÿ íåêîòîðûå ïðàêòè÷åñêèå îãðàíè÷åíèÿ, è ÿ ñîâåðøåííî íå óâåðåí, ÷òî îçîíîòåðàïèÿ çàéìåò ñòàáèëüíóþ ïîçèöèþ â ìåäèöèíñêîé ïðàêòèêå äî òåõ ïîð ïîêà íå áóäóò ïðîâåäåíû ñîîòâåòñòâóþùèå èññëåäîâàíèÿ. ...Âíèìàíèå äîëæíî áûòü óäåëåíî îöåíêå âîçìîæíîé îòäàëåííîé òîêñè÷íîñòè, ïðîâåäåíèþ ðàíäîìèçèðîâàííûõ, äâîéíûõ ñëåïûõ êëèíè÷åñêèõ èñûòàíèé ïî ñðàâíåíèþ êèñëîðîäíî-îçîíîâîé ñìåñè, îçîíà, è òðàäèöèîííîãî ëå÷åíèÿ ñ îöåíêîé îòäàëåííûõ ðåçóëüòàòîâ."
Áëàãîäàðÿ åãî äåÿòåëüíîñòè è ðàçóìíîé ïîçèöèè, ñòàëà âîçìîæíîé îðãàíèçàöèÿ îáúåêòèâíîé îöåíêè ìåòîäà ñ ñîáëþäåíèåì âñåõ ýòè÷åñêèõ íîðì êëèíè÷åñêèõ èññëåäîâàíèé, îòðàæåííûõ â Õåëüñèíñêîé äåêëàðàöèè (öèòàòà ïðèâåäåíà â ïðåäûäóùåì ñîîáùåíèè).

Íà âîïðîñû î ãåïàòèòå è ÂÈ×, ÿ óæå äàâàë îòâåòû, ïðèâåäÿ ïî âàøåìó òðåáîâàíèþ ñëåäóþùèå ññûëêè:

Infektionsgefahr durch Ozonterapie. Arznei-Telegramm 1991;6:56

Gabriel, C. et al "Transmission of Hepatitis C by Ozone Enrichment of Autologous Blood," Lancet, 1996;347:541j

Daschner FD. " Hepatitis C and human immunodeficiency virus infection following ozone autohaemotherapy."
Eur J Clin Microbiol Infect Dis. 1997 Aug;16(8):620.

Î äðóãèõ îñëîæíåíèÿõ íàïèñàíî â ýòîé ñòàòüå:
1.Oepen I, Eisenmenger W, Schmitt H, Maroske D.
Advantages and risks of ozone therapy
Offentl Gesundheitswes. 1983 Jul;45(7):323-6. German. , è äðóãèõ ïðèâåäåííûõ ðàáîòàõ äîêòîðà I.Oepen; à òàêæå â ðàáîòàõ èçðàèëüñêèõ ó÷åíûõ:
Avivi I. et. al. "Therapeutic potential of ozone - possible side-effects". 1996 Harefuah. Mar. 1; 130(5): 327-30
Weiner P. et al. "Ozone and its toxic effects" 1997 Harefuah. Nov. 2; 133(9): 381-3.

Îòäåëüíî îá ýìáîëèè èìåííî ïðè àóòîãåìîîçîíîòåðàïèè áûëî íàïèñàíî çäåñü:
Marchetti, D. et al. "Unexpected death during oxygen-ozone therapy" 2000, Am. J. Forensic. Med. Pathol. Vol.21 pp. 144-7.)

Êàê ýòî âûøëî, âîïðîñ íå êî ìíå, à ê òåì îçîíîòåðàïåâòàì, ó êîòîðûõ âñå ýòè îñëîæíåíèÿ èìåëè ìåñòî áûòü.

ß îçíàêîìèëñÿ ñî ìíîãèìè îáçîðíûìè ðàáîòàìè ïî îçîíîòåðàïèè â ðóññêèõ èñòî÷íèêàõ. Îá èõ îáúåêòèâíîñòè ìîæíî ñäåëàòü âûâîä, îçíàêîìèâøèñü ñî ñëåäóþùåé öèòàòîé èç îäíîé ðóññêîé ñòàòüè. "  ìèðîâîé ëå÷åáíîé ïðàêòèêå ïðèìåíÿþòñÿ ñïîñîáû ëîêàëüíîé ìåñòíîé òåðàïèè, ðåêòàëüíîå ââåäåíèå ãàçîîáðàçíîãî îçîíà, ìåòîäèêà áîëüøîé àóòîãåìîòåðàïèè, ìàëîé àóòîãåìîòåðàïèè, âíóòðèâåííîå, âíóòðèàðòåðèàëüíîå è âíóòðèñóñòàâíîå ââåäåíèå îçîíî-êèñëîðîäíûõ ñìåñåé. ÂÑÅ àâòîðû, ðàáîòàþùèå ñ ýòèìè ìåòîäèêàìè ïîä÷åðêèâàþò, ÷òî îçîíîòåðàïèÿ - ìîùíûé è ÁÅÇÎÏÀÑÍÛÉ ìåòîä ëå÷åíèÿ"  ýòîé ñòàòüå, êàê è âî âñåõ äðóãèõ, èíôîðìàöèÿ î òîì, ÷òî â ìèðîâîé ëå÷åáíîé ïðàêòèêå ýòîò ìåòîä ïðèíàäëåæèò àëüòåðíàòèâíîé ìåäèöèíå, è ëèøü èíîãäà èñïîëüçóåòñÿ â îôèöèàëüíîé êàê ýêñïåðèìåíòàëüíûé, óìàë÷èâàåòñÿ. Íè ñëîâà îá îñëîæíåíèÿõ.  ëó÷øåì ñëó÷àå ïðèâîäÿòñÿ ïðîòèâîïîêàçàíèÿ, à çà÷àñòóþ è î íèõ óìàë÷èâàåòñÿ.

Âåðí¸ìñÿ ê Bocci, Âû öèòèðóåòå: "ÌÛ ÌÎÃËÈ ÁÛ ñêîðî èìåòü ïðîñòóþ è íåäîðîãóþ òåðàïèþ, ÷òîáû âîññòàíîâèòü çäîðîâüå ìèëëèîíîâ ïàöèåíòîâ." Åñòåñòâåííî Bocci, êàê ïðåâåðæåíåö îçîíîòåðàïèè â ýòî âåðèò. Íî ãîâîðèò îá ýòîì ïîêà â óñëîâíîì íàêëîíåíèè.
Êàê âûøëî, ÷òî ïàöèåíòû Ðîññèè å¸ óæå èìåþò è âîññòàíàâëèâàþò ñâî¸ çäîðîâüå çà ñ÷åò ìåòîäèêè, êîòîðàÿ ïî ìíåíèþ îôèöèàëüíîé ìåäèöèíû âñåõ ñòðàí, êðîìå Êóáû, ÿâëÿåòñÿ â ëó÷øåì ñëó÷àå ýêñïåðèìåíòàëüíîé?  Âàøåì ïðåäûäóùåì ñîîáùåíèè Âû îïÿòü ïðèâîäèòå êàê äîêàçàòåëüñòâà öèòàòû ñî ñúåçäà îçîíîòåðàïåâòîâ, à íå îïóáëèêîâàííûå â ðåôåðèðóåìûõ æóðíàëàõ ñòàòüè.

À âîò êñòàòè, èíòåðåñíàÿ ðàáîòà ÿïîíñêèõ âåòåðèíàðîâ, êîòîðûå óçíàâ îá âîçìîæíîñòÿõ îçîíîòåðàïèè ïðè ïðèìåíåíèè íà ëþäÿõ, ðåøèëè ïðîâåðèòü å¸ ýôôåêòû íà êîðîâàõ. Âîò öèòàòà:
" Äëÿ ðÿäîâîãî âåòåðèíàðà-ïðàêòèêà, ïðåïÿòñòâèåì ê èñïîëüçîâàíèþ îçîíîòåðàïèè ïîìèìî ôàêòà àëüòåðíàòèâíîñòè ýòîãî ìåòîäà, ÿâëÿåòñÿ îïàñåíèå î âîçìîæíîé òîêñè÷íîñòè. Ïîýòîìó äëÿ òîãî, ÷òîáû èñïîëüçîâàíèå ýòîãî ìåòîäà in-vivo áûëî ýòè÷íûì, ìû ïðîâåëè ðÿä ýêñïåðèìåíòîâ in-vitro" Ðàáîòà îïóáëèêîâàíà â 2003 ãîäó. Íàäî äóìàòü, âñå îïóáëèêîâàííûå äî ñèõ ïîð ðàáîòû ïîêàçàëèñü âåòåðèíàðàì íåäîñòàòî÷íî óáåäèòåëüíûìè äëÿ ñìåëîãî èñïîëüçîâàíèÿ îçîíîòåðàïèè äàæå íà ÿïîíñêèõ êîðîâàõ. Âîò ýòà ðàáîòà Rio John T. Ducusin, Masakazu Nishimura, Takao Sarashina et al "Phagocytosis of Bovine Blood and Milk Polymorphonuclear Leukocytes after Ozone Gas Administration In Vitro". J.Vet,Med.Sci.65(4):535-539, 2003.

Âû ïðîñèëè ïðèâåñòè èìåíà ïðåäñòàâèòåëåé íåìåöêîé îôèöèàëüíîé ìåäèöèíû, "äàþùèõ îöåíêó îçîíîòåðàïèè", ÷òîáû ñ íèìè ñâÿçàòüñÿ. Âîò öèòàòà èç èíòåðâüþ ñ äîêòîðîì Áàðáàðoé Áóðêõàðä (Barbara Bukhard), ïðåäñòàâèòåëeì Medical Office of Patient Insurance-Bavaria (Munich, Germany): "Ozone therapy is not approved by the medical establishment in our country. The National Health Insurance (Gesetzliche Krankenversicherung) is not allowed to pay for it. In the book of laws on this subject (Sozial Gesetzbuch V), the obligations for insurance institutions are fixed. They are only required to pay for methods that are in accordance with generally accepted medical knowledge and which have made proven contributions in medicine. Doctors who have contracts with health insurance companies only get reimbursement for treatments that are approved by the Bundesausschub der Artz und Krankenkassen. This committee is governed by social insurance regulations and issues the rules for diagnostic and therapeutic medical methods. In an Appendix to their book of rules, methods not approved are listed. Ozone therapy is number 3 on that list."


À âîò èíòåðåñíàÿ èíôîðìàöèÿ îá ýêîíîìè÷åñêèõ àñïåêòàõ îçîíîòåðàïèè. Öèòàòà ñ ñàéòà [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

“3.4 Îêóïàåìîñòü çàòðàò
Çàòðàòû íà âíåäðåíèå òåõíîëîãèè îçîíîòåðàïèè îêóïèëèñü ìåíåå ÷åì çà 4 ìåñÿöà !

¹ Îêóïàåìîñòü çàòðàò 1 ìåñ. 2 ìåñ. 3 ìåñ. 4 ìåñ.
1 Åæåìåñÿ÷íàÿ âûðó÷êà 26180 26180 26180 26180
2 Åæåìåñÿ÷íûå ðàñõîäû 10652 10652 10652 10652
3 Åæåìåñÿ÷íàÿ ïðèáûëü 15528 15528 15528 15528
4 Ðàñõîäû íà îáîðóäîâàíèå 59683 0 0 0
Èòîãè äåÿòåëüíîñòè íàðàñòàþùèì èòîãîì -44155 -28627 -13099 2429


Âûâîä: Ïðèìåíåíèå îçîíîòåðàïèèè èìååò î÷åâèäíóþ ôèíàíñîâóþ âûãîäó, ÷òî îñîáåííî àêòóàëüíî â ÷àñòíîé ìåäèöèíñêîé ïðàêòèêå è ïðè îêàçàíèè ïëàòíûõ ìåäèöèíñêèõ óñëóã ïî ëèíèè ÎÌÑ. “

Çâó÷èò î÷åíü çàìàí÷èâî äëÿ ÷àñòíîïðàêòèêóþùåãî âðà÷à è îðãàíèçàöèé, îêàçûâàþùèõ ïëàòíûå óñëóãè ïî ëèíèè ÎÌÑ.


Åñëè Âàì èíòåðåñíî ìî¸ ëè÷íîå ìíåíèå, òî ÿ ñ÷èòàþ, ÷òî îçîíîòåðàïèÿ â òîì âèäå, â êîòîðîì îíà ñåé÷àñ ñóùåñòâóåò, ñêîðåå âñåãî íå ñìîæåò âûéòè èç êàòåãîðèè àëüòåðíàòèâíûõ ìåòîäèê. Îäíàêî, îçîí, êàê îáúåêò àêàäåìè÷åñêèõ èññëåäîâàíèé, -òåìà î÷åíü èíòåðåñíàÿ, îñîáåííî â ñâåòå ïîñëåäíèõ ðåâîëþöèîííûõ ðàáîò èç Scripps Reseach Institute. Ýòè èññëåäîâàíèÿ âîçìîæíî ïðèâåäóò ê ñîçäàíèþ ïðèíöèïèàëüíî íîâûõ ïîäõîäîâ â ìåäèöèíå, íî îíè âðÿä ëè áóäóò èìåòü ÷òî-òî îáùåå ñ îçîíèðîâàíèåì êðîâè è ïðî÷èìè ìåòîäàìè îçîíîòåðàïèè.

Óâàæàåìûé Âëàäèìèð ßêîâëåâè÷. Åùå ðàç ïîâòîðþ, ÷òî ìîè ñîîáùåíèÿ ÿâëÿþòñÿ ïîïûòêîé ïðîàíàëèçèðîâàòü èíôîðìàöèþ ïî îçîíîòåðàïèè. Îíè íè â êîåì ñëó÷àå íå èìåþ ñâîåé öåëüþ îáèäåòü Âàñ. Åñëè Âû ñ÷èòàåòå íåîáõîäèìûì óäàëèòü ìîè ñîîáùåíèÿ êàê ìîäåðàòîð - ýòî Âàøå ïðàâî.

Ñ óâàæåíèåì
Åâãåíèé Ñòóäåíöîâ, MD
Albert Einstein College of Medicine
  #27  
Ñòàðûé 29.09.2003, 12:40
V. ZAITSEV V. ZAITSEV âíå ôîðóìà Ïîë ìóæñêîé
çàáàíåí
      
 
Ðåãèñòðàöèÿ: 25.07.2001
Ñîîáùåíèé: 3,330
V. ZAITSEV
Óâàæàåìûé E.E. Studentsov!

Åñëè ó Âàñ åñòü òàêîå æåëàíèå ãîòîâ ïðîäîëæèòü îáñóæäåíèå è, åñëè ñìîãó ïîñòàðàþñü îòâå÷àòü íà âñå Âàøè âîïðîñû. Åñòåñòâåííî, êîððåêòíûå, îáîñíîâàííûå ñîîáùåíèÿ êðèòè÷åñêîãî ïëàíà íèêîìó â ãîëîâó óäàëÿòü íå ïðèäåò.

Òîëüêî íàïîìèíàþ ïðîñüáû, êîòîðûå ïèñàë ðàíåå:
«ß ñî ñâîåé ñòîðîíû òàêæå ïðåäëàãàþ, ÷òî äàâàéòå äîãîâîðèìñÿ, ÷òî íåïîäãîòîâëåííîñòü âðà÷åé, ïðàêòèêóþùèõ òó èëè èíóþ òåðàïèþ (â ÷àñòíîñòè, ÎÒ), íåñîâåðøåííîå îáîðóäîâàíèå øòàìïóåìîå, íåêîòîðûìè ïðîèçâîäèòåëÿìè è àãðåññèâíàÿ, áåçãðàìîòíàÿ êîììåð÷åñêàÿ ðåêëàìà ýòî îäíî, à îáúåêòèâíûå âîçìîæíîñòè, ìåõàíèçìû òåðàïèè – äðóãîå. À òàê, ê ïðèìåðó, ñàìûõ, ÷òî íè íà åñòü îðòîäîêñàëüíûõ âðà÷åé, êàê â Ðîññèè, òàê è â Àìåðèêå, ïðîïèñûâàþùèõ, íà âñÿêèé ñëó÷àé, «ñàìûå äîêàçàííûå» àíòèáèîòèêè ïðè âèðóñíûõ çàáîëåâàíèÿõ, èñõîäÿ èç ïðèíÿòîé íà ôîðóìå òåðìèíîëîãèè, ìîæíî ñ ïîëíûì ïðàâîì ïðè÷èñëèòü ê ØÀÐËÀÒÀÍÀÌ.
Âòîðîå, ïðè ïîäáîðå ìàòåðèàëà, ïî âîçìîæíîñòè, ñòàðàòüñÿ áûòü õîòÿ áû ÷óòî÷êó ìåíåå òåíäåíöèîçíûì. À òî äåëî äîõîäèò, ïðÿìî äî àíåêäîòè÷åñêèõ ïàðàëëåëåé.
Ê ïðèìåðó, êèñëîðîäà, êîòîðûé òàê õîðîøî ïîääåðæèâàåò ãîðåíèå, áîëüíèöû èñïîëüçóþò ñîòíè êóá.ì. â äåíü, òà æå áàðîêàìåðà, êîòîðàÿ ïðîïèñàíà â ñòàíäàðòàõ, äåéñòâèòåëüíî äîëæíà èìåòü î÷åíü âûñîêèå òðåáîâàíèÿ ïî ïðîòèâîïîæàðíîé áåçîïàñíîñòè, íî, èìåííî, ïî ïîâîäó îçîíîòåðàïåâòè÷åñêîãî îáîðóäîâàíèÿ, ïîòðåáëÿþùåãî íåçíà÷èòåëüíîå êîëè÷åñòâî êèñëîðîäà è ãåíåðèðóþùåãî, ñîâñåì íè÷òîæíîå êîëè÷åñòâî îçîíà, ïî÷åìó-òî íåîáõîäèìû òàêèå ãðîçíûå ïðîòèâîïîæàðíûå ïðåäóïðåæäåíèÿ».
Èëè, Åâãåíèé Åâãåíüåâè÷, Âû æå âèðóñîëîã. ß íåçíàêîì ñî ñòàòüÿìè, êîòîðûå Âû óïîìèíàåòå, íî ïðèâîäèòå îäíè íàçâàíèÿ. Íî êàê æå ìîæíî â âñåðüåç óòâåðæäàòü, ÷òî îçîíîòåðàïèÿ, à íå ïðîñòîå íåñîáëþäåíèå ýëåìåíòàðíûõ ïðàâèë ìàíèïóëÿöèé ñ êðîâüþ ïðèâåëè â çàðàæåíüÿì ãåïàòèòîì Ñ è ÂÈ×, ñåïñèñó è ãàíãðåíå. Òîëüêî â Ðîññèè óæå áîëåå äåñÿòè ëåò â ñîòíÿõ ËÓ åæåäíåâíî ïðîâîäÿòñÿ äåñÿòêè ñåàíñîâ ÎÒ. Ìíå íåèçâåñòíî íè îäíîãî ñëó÷àå òåõ óæàñîâ î êîòîðûõ Âû ïèøåòå. ß âåäü Âàñ óæå çäåñü ñïðàøèâàë: «Àóòîãåìîòåðàïèÿ – ðàáîòà ñ êðîâüþ ñàìîãî ïàöèåíòà. Ýòî êàê, áîëüíîé ñàì ñåáÿ çàðàçèë? Íå ãîâîðÿ óæ î òîì, ÷òî ïðèñóòñòâèå îçîíà, ïðè ëþáûõ ìàíèïóëÿöèÿõ ñ êðîâüþ, ìîæåò ëèøü ñíèçèòü âåðîÿòíîñòü çàðàæåíèÿ ãåïàòèòîì è ÂÈ×, ò.ê. îçîí in vitro èíàêòèâèðóåò âèðóñû. Òîæå ìîæíî ñêàçàòü î çàðàæåíèè áàêòåðèàëüíîé èíôåêöèåé (ñåïñèñ è ãàíãðåíû) ïðè ìàíèïóëÿöèÿõ â ïðèñóòñòâèè ñèëüíåéøåãî àíòèñåïòèêà – îçîíà. Èëè êòî-òî èñïîëüçîâàë øïðèöû ñ ïîìîéêè? Ïðè ÷åì çäåñü îçîíîòåðàïèÿ?» Âû îòâåòèëè? Òîæå êàñàåòñÿ ãàçîâîé ýìáîëèè ïðè àóòîãåìîòåðàïèè. Ñ òàêèì æå óñïåõîì ìîæíî ñîîáùèòü: ïðèíÿë àíòèáèîòèê, ïîñêîëüçíóëñÿ, óïàë, ñëîìàë íîãó. Âûâîä - àíòèáèîòèêè ñïîñîáñòâóþò ïåðåëîìàì. Íó ïî÷åìó æå âðà÷è íà ôîðóìå òàê ëþáÿò öèòèðîâàòü, öèòèðîâàòü è öèòèðîâàòü, íî ñîâñåì íå ëþáÿò ïðîñòî äóìàòü, ðàçìûøëÿòü? Êàê ÿ ìîãó ðåàãèðîâàòü, êîãäà áåññìûñëåííî ñâàëèâàþò â êó÷ó êàê ìîæíî áîëüøå íåãàòèâíîé èíôîðìàöèè, èãíîðèðóÿ ïðè ýòîì ëþáûå èññëåäîâàíèÿ ñ ïðîòèâîïîëîæíûìè ðåçóëüòàòàìè. Åâãåíèé Åâãåíüåâè÷, ÿ ïðèâîäèë íà ôîðóìå íè îäèí äåñÿòîê ýêñïåðèìåíòàëüíûõ è êëèíè÷åñêèõ ðàáîò, èç ðàçëè÷íûõ ñòðàí ìèðà â òîì ÷èñëå è ðàíäîìèçèðîâàííûõ. Âû õîòü íà îäíî îáðàòèëè âíèìàíèå, çàäàëè ïî èõ ïîâîäó õîòü îäèí âîïðîñ. È ïðè ýòîì Âû õîòèòå ñêàçàòü, ÷òî Âàøè ñîîáùåíèÿ íå èìåþò ÿâíî òåíäåíöèîçíûé õàðàêòåð?
Íå ñ÷èòàåòå ëè Âû, ÷òî äëÿ âûâîäîâ òèïà «ýòè èññëåäîâàíèÿ âîçìîæíî ïðèâåäóò ê ñîçäàíèþ ïðèíöèïèàëüíî íîâûõ ïîäõîäîâ â ìåäèöèíå, íî îíè âðÿä ëè áóäóò èìåòü ÷òî-òî îáùåå ñ îçîíèðîâàíèåì êðîâè è ïðî÷èìè ìåòîäàìè îçîíîòåðàïèè», íóæíî èìåòü îá ýòîé òåðàïèè áîëüøåå ïðåäñòàâëåíèå, ÷åì ÿâíî èçáèðàòåëüíîå ëèòåðàòóðíûé ïîèñê. À åù¸ ëó÷øå, õîòü êîãäà-òî, êàê-òî áûòü ñ íåé ñâÿçàííîé?
Åùå ðàç, ÿ ñîãëàñåí, áîëåå òîãî áóäó áëàãîäàðåí ëþáîé äèñêóññèè, åñëè ýòî äåéñòâèòåëüíî áóäåò äèñêóññèÿ, à íå îõàèâàíèå ïî ëè÷íîñòíûì ñîîáðàæåíèÿì.
Âû ìîæåòå ñêîëü óãîäíî ýòî îòðèöàòü, íî ÿ óâåðåí, ÷òî Âû âðÿä ëè îáðàòèëè áû âíèìàíèå íà ýòó òåðàïèè, ïîòðàòèëè áû âðåìÿ íà ïîèñê, åñëè áû íå òîò àíòàãîíèçì, êîòîðûé ñëîæèëñÿ â íàøèõ îòíîøåíèÿõ.
  #28  
Ñòàðûé 29.09.2003, 13:26
V. ZAITSEV V. ZAITSEV âíå ôîðóìà Ïîë ìóæñêîé
çàáàíåí
      
 
Ðåãèñòðàöèÿ: 25.07.2001
Ñîîáùåíèé: 3,330
V. ZAITSEV
Äà, åù¸.
Äî òîãî, êàê ÎÒ â Ðîññèè ñòàëè èñïîëüçîâàòü â êëèíè÷åñêîé ïðàêòèêå, â 70- 80 ãîäû ïðîøëîãî âåêà, ïàðàëëåëüíî â íåñêîëüêèõ èññëåäîâàòåëüñêèõ öåíòðàõ áûëè ïðîâåäåíû ñîòíè ýêñïåðèìåíòàëüíûõ ðàáîò ñ óïîðîì, ïîíà÷àëó, íà òîêñèêîëîãèþ, ìóòàãåííîñòü. Çàòåì ó êðûñ è ñîáàê ìîäåëèðîâàëèñü ðàçëè÷íûå ïàòîëîãèè. Âñå ýòè èññëåäîâàíèÿ ñîïðîâîæäàëèñü âñåâîçìîæíûìè áèîõèìè÷åñêèìè, èììóíîëîãè÷åñêèìè, ìîðôîëîãè÷åñêèìè, ìèêðîáèîëîãè÷åñêèìè àíàëèçàìè è çàíÿëè íè îäèí ãîä. È ýòî ïðè òîì, ÷òî ÎÒ â òî âðåìÿ óæå ïðèìåíÿëàñü â òîé æå Êóáå, Ãåðìàíèè è äð.
  #29  
Ñòàðûé 15.10.2003, 22:23
V. ZAITSEV V. ZAITSEV âíå ôîðóìà Ïîë ìóæñêîé
çàáàíåí
      
 
Ðåãèñòðàöèÿ: 25.07.2001
Ñîîáùåíèé: 3,330
V. ZAITSEV
Ê âîïðîñó îá îáúåêòèâíîñòè.

Óâàæàåìûé E.E. Studentsov, ïðè äåìîíñòðàöèè êàêîå çëî âååò îò îçîíîòåðàïèè è îò ïðåäñòàâèòåëÿ ýòîé òåðàïèè íà ôîðóìå ñîñëàëñÿ òàêæå íà ðàíåå íåèçâåñòíóþ ìíå ðàáîòó ÿïîíñêèõ âåòåðèíàðîâ.
Îí ïèøåò: À âîò êñòàòè, èíòåðåñíàÿ ðàáîòà ÿïîíñêèõ âåòåðèíàðîâ, êîòîðûå óçíàâ îá âîçìîæíîñòÿõ îçîíîòåðàïèè ïðè ïðèìåíåíèè íà ëþäÿõ, ðåøèëè ïðîâåðèòü å¸ ýôôåêòû íà êîðîâàõ. Âîò öèòàòà:
" Äëÿ ðÿäîâîãî âåòåðèíàðà-ïðàêòèêà, ïðåïÿòñòâèåì ê èñïîëüçîâàíèþ îçîíîòåðàïèè ïîìèìî ôàêòà àëüòåðíàòèâíîñòè ýòîãî ìåòîäà, ÿâëÿåòñÿ îïàñåíèå î âîçìîæíîé òîêñè÷íîñòè. Ïîýòîìó äëÿ òîãî, ÷òîáû èñïîëüçîâàíèå ýòîãî ìåòîäà in-vivo áûëî ýòè÷íûì, ìû ïðîâåëè ðÿä ýêñïåðèìåíòîâ in-vitro" Ðàáîòà îïóáëèêîâàíà â 2003 ãîäó. Íàäî äóìàòü, âñå îïóáëèêîâàííûå äî ñèõ ïîð ðàáîòû ïîêàçàëèñü âåòåðèíàðàì íåäîñòàòî÷íî óáåäèòåëüíûìè äëÿ ñìåëîãî èñïîëüçîâàíèÿ îçîíîòåðàïèè äàæå íà ÿïîíñêèõ êîðîâàõ. Âîò ýòà ðàáîòà Rio John T. Ducusin, Masakazu Nishimura, Takao Sarashina et al "Phagocytosis of Bovine Blood and Milk Polymorphonuclear Leukocytes after Ozone Gas Administration In Vitro". J.Vet,Med.Sci.65(4):535-539, 2003.

×èòàþùèì ýòè ñðîêè íàâåðíîå ïîäóìàëîñü, ÷òî Åâãåíèé Åâãåíüåâè÷, ïî-âèäèìîìó, ðåøèë ïîùàäèòü ýòîãî ôðóêòà Â. Çàéöåâà, ðàç ñêðîìíî óìîë÷àë î ïîëó÷åííûõ ýòèõ ðàáîòàõ óäðó÷àþùèõ äëÿ îçîíà ðåçóëüòàòàõ.

Ïðèâîæó àííîòàöèþ ðàáîòû.

J Vet Med Sci. 2003 Apr;65(4):535-9.
Phagocytosis of bovine blood and milk polymorphonuclear leukocytes after ozone gas administration in vitro.

Ducusin RJ, Nishimura M, Sarashina T, Uzuka Y, Tanabe S, Otani M.

Department of Veterinary Clinical Science, The United Graduate School of Veterinary Sciences, Gifu University, Yanagido, Japan.

To determine the effects of ozone on the phagocytosis of bovine polymorphonuclear leukocytes (PMNs), ozone gas was administered in vitro on the blood and milk of healthy lactating cows, cows with acute mastitis, and cows with milk fever. In the blood of healthy dairy cattle, although there was no significant effect of ozone gas on the viability of the leukocytes, phagocytosis of PMNs significantly decreased. In contrast, ozone gas administration in vitro significantly increased phagocytosis of PMNs from the blood of cows with acute mastitis and milk fever, and from mastitic milk. These findings showed that ozone administration in vitro has positive and negative effects on bovine PMN phagocytosis, depending on the health status of the animal.

PMID: 12736440 [PubMed - indexed for MEDLINE]

Êîíå÷íî, îáíàðóæåííîå ÿïîíñêèìè âåòåðèíàðàìè çíà÷èòåëüíîå ïîñëå îçîíà ïîâûøåíèå ôàãîöèòîçà ó íåçäîðîâûõ êîðîâ íè ÷åãî íîâîãî äëÿ ÎÒ íå äîáàâèëî. Ýòîò ìíîãî ðàç ôèêñèðîâàëîñü, êàê ó æèâîòíûõ, òàê è ó áîëüíûõ çàäîëãî äî èõ èññëåäîâàíèé. ( òîì ÷èñëå è ñ ã-íîì Çàéöåâûì, ñ êîòîðûì «íè îäèí ïðèëè÷íûé ÷åëîâåê ðàçãîâàðèâàòü íå äîëæåí»). Íî ïî÷åìó æå ñêàçàâ À, Åâãåíèé Åâãåíüåâè÷, ïîñòåñíÿëñÿ áóêâû Á?
  #30  
Ñòàðûé 06.12.2003, 17:47
E.E. Studentsov E.E. Studentsov âíå ôîðóìà
Çàñëóæåííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 29.06.2003
Ãîðîä: New York, USA
Ñîîáùåíèé: 834
Ñêàçàë(à) ñïàñèáî: 2
Ïîáëàãîäàðèëè 6 ðàç(à) çà 4 ñîîáùåíèé
E.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåE.E. Studentsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ïåðåíîñ ñ ôîðóìà ïî ãèíåêîëîãèè äëÿ ïàöèåíòîâ.

Óâàæàåìûé Âëàäèìèð ßêîâëåâè÷,

Ïîíèìàÿ Âàøè ïàòðèîòè÷åñêèå ÷óâñòâà, ïîñïåøó çàâåðèòü ÷òî ÿ íè â êîåé ìåðå íå óñîìíèëñÿ â ïðîôåññèîíàëèçìå âñåõ ðîññèéñêèõ ãèíåêîëîãîâ. À ëèøü âûñòóïèë ñ êðèòèêîé ïî ïîâîäó îäíîé êîíêðåòíîé ãðóïïû âðà÷åé. Ìîÿ îñâåäîìë¸ííîñòü â îáëàñòè ïàïèëëîìàâèðóñíîé èíôåêöèè íåñêîëüêî îòëè÷àåòñÿ îò Âàøèõ íàèâíûõ ðàññóæäåíèé. Ïîýòîìó ñëàáûõ ìåñò â ìîèõ ïîñòàõ íå èùèòå, ò.ê. êîíêðåòíî Âàì èõ íåïî÷¸ì íå ñûñêàòü. ×òî êàñàåòñÿ âàëòðåêñà è ïàïèëëîìàâèðóñà â Ðîññèè - ñëó÷àé ê ñîæàëåíèþ âîïèþùèé è íå åäèíñòâåííûé.  äîêàçàòåëüñòâî ïðèâåäó âûäåðæêó èç èíòåðíåò-êîíñóëüòàöèè âðà÷à "âàëòðåêñîâñêîãî íàïðàâëåíèÿ":

ÂÎÏÐÎÑ ÏÀÖÈÅÍÒÀ:
22/10/2003, Àíîíèì
"Ïîñòàâëåí äèàãíîç äèñïëàçèÿ øåéêè ìàòêè. Ñäàëà àíàëèçû íà ãåðïåñ âèðóñ-îòðèöàòåëüíûé. Íà ïàïïèëîìîâèðîñ - êîýôôèöèåíò 3,8 (íîðìà íàïèñàíî äî 1). 28 îêòÿáðÿ íà ïðèåì ê âðà÷ó, íî ìûñëè î ñàìîì ñòðàøíîì. Òðè ãîäà äåëàëè àíàëèç íà îíêîëîãèþ-âñå áûëî íîðìàëüíî. Ïðè êîëüïîñêîïèè ïëîõî îêðàøèâàëîñü, íà âèðóñû àíàëèçû ñäàâàëà âïåðâûå.  äèàãíîçå åñòü ìèîìà, íî íåáîëüøàÿ è íåìíîãî óìåíüøèëàñü. Êàêîå ëå÷åíèå ïîñîâåòîâàëè áû Âû. ×èòàëà î ïðåïàðàòå Ëèêîïèä.  àííîòàöèè íàïèñàíî, ÷òî ïîìîãàåò è ïðè ïñîðèàçå. Ïñîðèàçîì áîëåþ 20 ëåò, íî ó íàñ Ðîññèéñêèõ ïðåïàðàòîâ ïðàêòè÷åñêè íåò. Ìîæíî ëè åãî ïðèîáðåñòè áåç ðåöåïòà â Ðîññèè, åñëè, íà Âàø âçãëÿä, îí íåîáõîäèì ìíå äëÿ ëå÷åíèÿ.

ÎÒÂÅÒ ÃÈÍÅÊÎËÎÃÀ:
Âèðóñ ïàïèëëîìû íàäî îïðåäåëèòü ìåòîäîì ÄÍÊ (ÏÖÐ), ñ ïîäðàçäåëåíèåì íà ãðóïïû âûñîêîãî è íèçêîãî ðèñêà îíêîãåííîñòè. Ýòîò âèðóñ âèíîâàò â ôîðìèðîâàíèè äèñïëàçèè øåéêè ìàòêè. Íî îäíîãî Ëèêîïèäà ìàëî äëÿ ëå÷åíèÿ. Ïðåäëàãàþ êóðñ ïðîòèâîâèðóñíîãî ëå÷åíèÿ äëÿ Âàñ è Âàøåãî ñóïðóãà: ïðåïàðàò Ôàìâèð (Ôàìöèêëîâèð) ïî 500 ìã 2 ðàçà èëè Âàëòðåêñ (Âàëöèêëîâèð), â òîé æå äîçå - 5 äíåé; ïðåïàðàò Àìèêñèí ïî 2 òàáëåòêè 2 äíÿ, çàòåì ïî 1 òàáëåòêå ÷åðåç äåíü 4 íåäåëè; óêîëû Íåîâèð íàäî äåëàòü âíóòðèìûøå÷íî 2 ðàçà â íåäåëþ, êóðñ èç äåñÿòè èíúåêöèé: ñíà÷àëà 5 óêîëîâ ÷åðåç äåíü, çàòåì – 2 íåäåëè – ïåðåðûâ è åùå 5 óêîëîâ. Ôàìâèð è Àìèêñèí íà÷íèòå ïðèíèìàòü â äåíü 2-îé èíúåêöèè Íåîâèð. Âî âëàãàëèùå âïðûñêèâàéòå æèäêîñòü Ýïèãåí-èíòèì. Òàáëåòêè è óêîëû Âàø ñóïðóã èëè ïàðòíåð äîëæåí ïðèíèìàòü âìåñòå ñ Âàìè. ×åðåç ìåñÿö ïîñëå îêîí÷àíèÿ ëå÷åíèÿ íàäî îáîèì ñäàòü ïîâòîðíûå àíàëèçû ìåòîäîì ÄÍÊ (êîëè÷åñòâåííûé). Ïîëîâàÿ æèçíü - òîëüêî ñ èñïîëüçîâàíèåì ïðåçåðâàòèâà äî ïîëó÷åíèÿ ðåçóëüòàòîâ ïîâòîðíûõ àíàëèçîâ".

ÂÎÏÐÎÑ ÏÀÖÈÅÍÒÀ:
21/08/2003, Àíîíèì
Ìíå 19 ëåò, è ó ìåíÿ îáíàðóæèëè ïàïèëëîìàâèðóñ 16 ñåðîòèïà â î÷åíü-î÷åíü áîëüøîì êîëè÷åñòâå. Âðà÷ó ÿ äîâåðÿþ ïîëíîñòüþ, íî ó íåãî ñïðàøèâàòü êàê-òî íåóäîáíî: ñêàæèòå, ïîæàëóéñòà, (ÿ ïîíèìàþ, ÷òî ó âñåõ âñå èíäèâèäóàëüíî) êàêîé ìîæåò áûòü ïðîãíîç ðàçâèòèÿ çàáîëåâàíèÿ â ñàìîì õóäøåì ñëó÷àå, ÿ èìåþ â âèäó ïî ñðîêàì. Êàê ÿ ïîíÿëà ïîëîæåíèå îñëîæíÿåòñÿ åùå è íàëè÷èåì âèðóñà ãåðïåñà (àíàëèçîâ íà îïðåäåëåíèå ýòîãî âèðóñà íå äåëàëè, ìåíÿ íè÷åãî íå áåñïîêîèò, íî ïî ìàçêàì î÷åíü âûñîêèå ëåéêîöèòû, à âñå îñòàëüíûå èíôåêöèè èñêëþ÷åíû, äàæå óðåàïëàçìà, êîòîðàÿ ìîæåò äàâàòü òàêèå ëåéêîöèòû). À ìíå î÷åíü õî÷åòñÿ èìåòü äåòåé, íî ñåé÷àñ âðîäå åùå è ðàíî, à ìîæåò, ëåò ÷åðåç 5 áóäåò óæå ñëèøêîì ïîçäíî? ß âîâñå íå ïàíèêóþ. Ïðîñòî ïðåäóïðåæäåí - çíà÷èò âîîðóæåí!

ÎÒÂÅÒ ÃÈÍÅÊÎËÎÃÀ:
Âèðóñ ïàïèëëîìû 16 ìîðôîòèïà - ñàìûé îíêîãåííûé.  60-75% ñëó÷àåâ îí ïðèâîäèò ê çëîêà÷åñòâåííîìó ïåðåðîæäåíèþ òîé èëè òåõ òêàíåé, ãäå îí ðàçìíîæàåòñÿ. Îí ìîæåò âûçâàòü ðàê øåéêè ìàòêè, êîæè è ñëèçèñòîé íàðóæíûõ ïîëîâûõ îðãàíîâ è âëàãàëèùà. Ïðîâåäèòå òàêîå ëå÷åíèå. Ïðåäëàãàþ êóðñ ïðîòèâîâèðóñíîãî ëå÷åíèÿ äëÿ Âàñ è Âàøåãî ñóïðóãà: ïðåïàðàò Ôàìâèð (ôàìöèêëîâèð) ïî 500 ìã 2 ðàçà èëè Âàëòðåêñ (Âàëöèêëîâèð), â òîé æå äîçå - 5 äíåé; ïðåïàðàò Àìèêñèí ïî 2 òàáëåòêè 2 äíÿ, çàòåì ïî 1 òàáëåòêå ÷åðåç äåíü, 4 íåäåëè; óêîëû Íåîâèð íàäî äåëàòü âíóòðèìûøå÷íî 2 ðàçà â íåäåëþ, êóðñ èç äåñÿòè èíúåêöèé: ñíà÷àëà 5 óêîëîâ ÷åðåç äåíü, çàòåì – 2 íåäåëè – ïåðåðûâ è åùå 5 óêîëîâ, ýòî èììóíîñòèìóëÿöèÿ. Äîïîëíèòåëüíîé èììóíîñòèìóëÿöèåé ïðîòèâ ïàïèëëîìà-âèðóñà áóäóò òàáëåòêè Ëèêîïèä ïî 10 ìã, êîòîðûå íàäî ðàññàñûâàòü ïî 1 øò. ÷åðåç äåíü. Ôàìâèð è Àìèêñèí íà÷íèòå ïðèíèìàòü â äåíü 2-îé èíúåêöèè Íåîâèð. Âî âëàãàëèùå è íà íàðóæíûå ïîëîâûå îðãàíû âïðûñêèâàéòå æèäêîñòü Ýïèãåí-èíòèì. Òàáëåòêè è óêîëû Âàø ñóïðóã èëè ïàðòíåð äîëæåí ïðèíèìàòü âìåñòå ñ Âàìè. ×åðåç ìåñÿö ïîñëå îêîí÷àíèÿ ëå÷åíèÿ ñäàäèòå âìåñòå ïîâòîðíûå àíàëèçû, òàêæå ÄÍÊ."

Ñàìîå èíòåðåñíîå â ýòèõ êîíñóëüòàöèÿõ, ÷òî ýòî âðàíü¸ ïðàêòè÷åñêè îò ïåðâîãî è äî ïîñëåäíåãî ñëîâà. À òåïåðü, Âëàäèìèð ßêîâëåâè÷, Âû ìîæåòå ïðåäñòàâèòü äóøåâíîå ñîñòîÿíèå äåâÿòíàäöàòèëåòíåé äåâóøêè, êîòîðîé âðà÷-ãèíåêîëîã çàÿâëÿåò ÷òî èíôåêöèÿ ÂÏ× 16-ãî òèïà â 75% ñëó÷àåâ ïðèâîäèò ê ðàêó. Îòâåòû ýòîãî âðà÷à ïðàêòè÷åñêè ïî âñåì âîïðîñàì ó ñïåöèàëèñòîâ âûçûâàþò óæàñ. À êëèíèêà-òî ñîëèäíàÿ, è öåíû íà ëå÷åíèå äàëåêî íå íèçêèå.

Ñ óâàæåíèåì
Å.Å. Ñòóäåíöîâ
 



Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 20:06.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.